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Résumé en Français 
 
Introduction 
 
Les mitochondries constituent un réseau hautement dynamique 
Les mitochondries jouent un rôle fondamental dans de nombreux processus 
cellulaires, intervenant dans la production d’énergie, l’équilibre ionique ou 
encore le vieillissement et la mort cellulaire programmée (Desagher and 
Martinou, 2000; Rizzuto et al., 2000; Wallace, 2005). Dans la plupart des 
cellules eucaryotes, les mitochondries constituent des réseaux dont la forme et 
la taille varient en réponse aux demandes cellulaires et aux conditions 
environnementales (Bereiter-Hahn and Voth, 1994). La morphologie du réseau 
mitochondrial dépend de l’équilibre entre les événements de fusion et de fission 
(Okamoto and Shaw, 2005). Si l’équilibre est déplacé vers la fission, les 
mitochondries adoptent un aspect fragmenté alors que si la fusion prévaut, le 
réseau prend une forme allongée et interconnectée. Le déséquilibre de la 
dynamique mitochondriale a des conséquences graves sur la physiologie 
cellulaire et est associé à des défauts de développement, ainsi qu’à certaines 
pathologies neurodégéneratives (Bossy-Wetzel et al., 2003; Chan, 2006).  Les 
mécanismes régulant la morphologie mitochondriale ne sont pas totalement 
compris, néanmoins plusieurs protéines jouant un rôle clé dans l’équilibre 
fusion/fission ont été identifiées. 
 
La fusion des mitochondries 
La fusion est importante pour la transmission et le maintien de l’intégrité de 
l’ADN mitochondrial (ADNmt) (Ono et al., 2001; Legros et al., 2004). Le génome 
mitochondrial étant présent en plusieurs copies dans les cellules eucaryotes, 
l’émergence de mutations dans l’ADNmt peut conduire à une hétéroplasmie, 
l’ADN  muté coexistant avec l’ADN normal. L’amplification des copies mutées 
conduit à un dysfonctionnement des organites et est associée à de nombreuses 
pathologies humaines (Lightowlers et al., 1997). La complémentation intra-
mitochondriale est un phénomène important qui permet d’endiguer l’expansion 
et la transmission des mutations hétéroplasmiques et d’éviter ainsi le 
dysfonctionnement des mitochondries. Les mécanismes de complémentation et 
de ségrégation de l’ADNmt sont peu connus, néanmoins, la fusion des 
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mitochondries y joue un rôle majeur (Legros et al., 2004).  Chez les 
mammifères, la fusion des mitochondries dépend de protéines appelées 
Mitofusines (Mfn1 et Mfn2) (Santel and Fuller, 2001; Legros et al., 2002; Chen 
et al., 2003; Santel et al., 2003). Ces GTPases sont localisées sur la membrane 
mitochondriale externe et leur délétion conduit à une morphologie fragmentée 
du réseau mitochondrial (Chen et al., 2003; Ishihara et al., 2004). Opa1, une 
autre GTPase située sur la membrane mitochondriale interne, participe 
également à la fusion mitochondriale (Cipolat et al., 2004). L’interaction en 
trans des Mitofusines semble cruciale pour la fusion de la membrane externe, 
alors que le mécanisme de fusion de la membrane interne reste peu connu 
(Koshiba et al., 2004).   
 
La fission des mitochondries 
La fission est essentielle pour la répartition égale des mitochondries entre les 
cellules filles au cours des divisions cellulaires. Chez les mammifères, ce 
processus implique deux protéines : Drp1 (Dynamin-related protein 1) et  Fis1 
(Smirnova et al., 1998; Pitts et al., 1999; Smirnova et al., 2001; Yoon et al., 
2001; James et al., 2003; Stojanovski et al., 2004). Drp1 est une GTPase de la 
famille des dynamines, dont la distribution est principalement cytosolique mais 
qui est également associée aux sites de scission des mitochondries (Shaw and 
Nunnari, 2002; Osteryoung and Nunnari, 2003). Le mode d’action de Drp1 est 
probablement semblable à celui de la dynamine, une mécano-enzyme qui 
utilise l’énergie libérée par l’hydrolyse du GTP pour former un anneau autour du 
goulot des vésicules d’endocytose (Hinshaw, 2000; Danino and Hinshaw, 2001; 
Song and Schmid, 2003; Praefcke and McMahon, 2004). En effet chez la levure 
l’homologue de Drp1 multimérise et forme des spirales autour de la 
mitochondrie, la constriction de ces structures pouvant conduire à la division de 
l’organite (Fukushima et al., 2001; Zhu et al., 2004; Ingerman et al., 2005). Le 
recrutement de Drp1 à la surface des mitochondries nécessite la présence de 
Fis1 (James et al., 2003; Stojanovski et al., 2004). Cette protéine de 17 kd est 
répartie de façon homogène sur la membrane mitochondriale externe.  Son N-
terminus est exposé au cytosol et elle comporte un domaine transmembranaire 
suivi de quelques acides aminés se trouvant dans l’espace intermembranaire. 
Dans la levure, Fis1 recrute deux autres protéines qui participent au 
mécanisme de division : Mdv1p et Caf4p (Tieu et al., 2002; Griffin et al., 2005). 
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A ce jour aucun homologue n’a été trouvé chez les mammifères, mais il est 
probable que d’autres protéines entrent dans la composition du complexe de 
division.  
 
La dynamique mitochondriale et le métabolisme énergétique  
La majorité des cellules eucaryotes tirent un maximum de leur énergie de 
l’oxydation du glucose, un processus qui peut être séparé en deux étapes 1) 
une étape cytosolique, la glycolyse, qui transforme le glucose en pyruvate et 
produit 4 molécules d’ATP 2) une étape mitochondriale qui comprend le cycle 
de l’acide citrique dans la matrice et la phosphorylation oxydative dans la 
membrane mitochondriale interne et qui génère 10 molécules d’ATP par 
molécule de pyruvate. Le pyruvate est oxydé par le cycle de l’acide citrique afin 
de générer un pouvoir réducteur qui sera utilisé par la suite par la chaîne de 
transport d’électrons et l’ATP synthase pour produire de l’ATP. Le métabolisme 
énergétique cellulaire dépend de nombreux facteurs, la cellule pouvant moduler 
l’une ou l’autre des voies de production d’ATP. Les altérations du métabolisme 
énergétique ont des conséquences catastrophiques sur la survie des cellules et 
sont à la base de nombreuses maladies (Wallace, 2005). La disponibilité en 
oxygène, l’abondance des nutriments, la nature du substrat présent dans le 
milieu, la présence de facteurs de croissance et d’hormones, le stade de 
différentiation et l’avancée du cycle cellulaire sont autant de paramètres qui 
régulent la production d’énergie. De façon similaire, la morphologie des 
mitochondries varie considérablement avec le métabolisme énergétique et en 
fonction de l’activation de la respiration mitochondriale (Hackenbrock, 1966, 
1968; Hackenbrock et al., 1971). D’une part le réseau mitochondrial adopte une 
forme plus interconnectée lorsque la respiration est activée (Hoffmann and 
Avers, 1973; Visser et al., 1995; Egner et al., 2002; Rolland et al., 2002; 
Rossignol et al., 2004). D’autre part, la délétion des Mitofusines ou de Opa1 
provoque l’émergence d’un défaut énergétique et favorise la glycolyse au 
détriment du cycle de l’acide citrique et de la phosphorylation oxydative (Chen 
et al., 2005). A l’inverse, la surexpression des protéines de fusion active la 
phosphorylation oxydative (Pich et al., 2005).  
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La dynamique mitochondriale et la mort cellulaire programmée (apoptose) 
Un des changements les plus dramatiques de la morphologie mitochondriale 
est  observé pendant l’apoptose. Au cours de l’apoptose, les mitochondries se 
fragmentent (Martinou et al., 1999; Frank et al., 2001; Karbowski et al., 2002; 
Reed and Green, 2002; Lee et al., 2004) suggérant que ce processus pouvait 
jouer un rôle dans la perméabilisation de la membrane mitochondriale externe 
(Perfettini et al., 2005). La perméabilisation de la membrane mitochondriale 
externe est une étape clé du programme de mort cellulaire programmée car elle 
conduit à la libération dans le cytosol de proteins, telles que le cytochrome c, 
qui activent la cascade des caspases. Parmi les signaux pouvant provoquer 
cette perméabilisation certains impliquent l’activation de protéines 
proapoptotiques de la famille de Bcl2. D’autres requièrent la libération des 
stocks intracellulaires de Ca2+ et l’ouverture du Pore de Transition (PTP). De 
nombreuses études semblent indiquer que les protéines de fission et de fusion 
influencent également la perméabilisation des mitochondries. Ainsi la déplétion 
de Drp1 ou de hFis1 et la surexpression de Mfn1 ou d’Opa1 protègent contre 
de nombreux stimuli apoptotiques (Frank et al., 2001; Lee et al., 2004; Sugioka 
et al., 2004; Germain et al., 2005; Frezza et al., 2006). Au contraire, la déplétion 
d’Opa1 sensibilise les cellules aux stimuli de mort et l’expression de hFis1 
provoque l’hyper fragmentation mitochondriale, la perméabilisation de la 
membrane mitochondriale externe et la mort des cellules (James et al., 2003; 
Lee et al., 2004). 
 
But de la thèse 
La morphologie du réseau mitochondrial est donc intimement liée à la 
physiologie cellulaire. L’étude des mécanismes qui gouvernent les 
changements morphologiques de ce réseau est cruciale pour la compréhension 
du rôle polyvalent des mitochondries dans les cellules mammifères. La 
participation des mitochondries dans l’apoptose notamment en fait une cible de 
choix pour le développement de nouvelles molécules anti-cancéreuses (Don 
and Hogg, 2004; Weissig et al., 2004; Armstrong, 2006).  Afin de clarifier la 
relation qui existe entre fission mitochondriale et apoptose, nous nous sommes 
intéressés à hFis1, le récepteur présumé des molécules de fission. Dans un 
premier temps, nous avons tenté d’identifier les protéines interagissant avec 
hFis1. Afin de comprendre l’importance relative des différents domaines de la 
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protéine, nous avons également entrepris une analyse mutationnelle de hFis1. 
Nous avons ainsi montré que la partie cytosolique de hFis1 est essentielle à sa 
fonction alors que la partie transmembranaire est responsable de son 
adressage et de sa dimérisation. Par la suite nous nous sommes intéressés au 
mécanisme impliqué dans la mort induite par hFis1. La combinaison d’une 
approche génétique avec l’analyse de mutants de hFis1 nous a permis de 
montrer que la fission mitochondriale est dissociée de la mort induite par hFis1. 
D’autre part nous avons observé que les protéines proapoptotiques de la 
famille de Bcl2 ne sont pas directement impliquées, mais que hFis1 sollicite la 
voie calcique et le Réticulum Endoplasmique (RE) pour tuer. Cette étude est la 
première à dissocier clairement fragmentation mitochondriale et apoptose, et 
met en évidence une fonction insoupçonnée de hFis1. 
 
hFis1, un rôle au-delà de la fission mitochondriale ? 
 
hFis1 contrôle la forme des mitochondries 
La surexpression de hFis1 dans les cellules mammifères induit une 
fragmentation massive des mitochondries et conduit à la mort cellulaire. 
Comme le montre le test de fusion, la fragmentation mitochondriale induite par 
hFis1 n’est pas due à une inhibition de la fusion, mais bien à une activation de 
la fission. A l’inverse, sa déplétion par RNAi cause une légère élongation du 
réseau mitochondrial et protège de la mort induite par différents stimuli (Lee et 
al., 2004). Afin de mieux caractériser les différents domaines de hFis1, nous 
avons généré plusieurs mutants, et enlevé des portions de la molécule aussi 
bien en N-terminus (hFis1ΔN-term) qu’en C-terminus (hFis1ΔC-term). Cette approche 
nous a permis de montrer que le domaine C-terminal est responsable de 
l’adressage de hFis1 à la membrane mitochondriale externe, la forme hFis1ΔC-
term étant cytosolique. Les hélices du domaine TPR sont essentielles aussi bien 
à la fission qu’à la fusion des mitochondries. En effet, en présence de hFis1ΔN-
term, les mitochondries apparaissent gonflées et forment des agrégats autour du 
noyau. 
 
hFis1 induit l’autophagie et l’apoptose 
La surexpression de hFis1 conduit non seulement à la fragmentation 
mitochondriale mais également au relargage du cytochrome c et à l’activation 
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des caspases. En outre, elle est associée à la formation d’autophagosomes 
dans le cytosol et à une hétérogénéité du potentiel de membrane, révélateurs 
d’un dysfonctionnement mitochondrial. La mort induite par hFis1 semble donc 
découler de la combinaison des programmes d’apoptotose et d’autophagie. Le 
mutant hFis1ΔN-term quant à lui induit l’autophagie sans induire l’apoptose, 
indiquant que les deux processus peuvent être dissociés. 
 
hFis1 affecte l’homéostase calcique 
Les mitochondries jouent un rôle majeur dans l’homéostase calcique, et 
modulent notamment les signaux Ca2+ issus du Réticulum Endoplasmique. 
L’effet drastique de hFis1 sur la morphologie mitochondriale laissait envisager 
que les flux calciques entre la mitochondrie et le RE seraient perturbés par sa 
surexpression. Néanmoins, la mesure de la concentration de Ca2+ dans ces 
deux organites révèle que les stocks intracellulaires du RE sont plus bas alors 
que la concentration de Ca2+ dans la mitochondrie reste inchangée. Cet effet 
sur le Calcium du RE est très probablement indirect, la morphologie de cet 
organite restant inaltérée par la surexpression de hFis1.  
 
Les partenaires de hFis1 
hFis1 est considéré comme le récepteur de la machinerie de division 
mitochondriale. Cependant, aucune autre protéine régulant la dynamique 
mitochondriale n’interagit avec hFis1 dans le système double hybride. 
L’absence d’homologues de Mdv1p et de Caf4p chez les mammifères laisse 
envisager l’existence d’autres protéines médiatrices intervenant dans la fission. 
Afin d’identifier ces protéines nous avons effectué un screen double-hybride et 
isolé des partenaires potentiels. D’autres part, la combinaison du double 
hybride et d’approches biochimiques nous a permis de montrer que hFis1 
dimérise.  Enfin, malgré plusieurs tentatives, nous n’avons pas été en mesure 
d’isoler de complexe de fission, ce qui semble indiquer que les associations 
protéiques établies par hFis1 sont transitoires ou faibles. 
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L’apoptose induite par hFis1 implique le Reticulum Endoplasmic  
 
L’apoptose induite par hFis1 est indépendante de son rôle dans la fission 
mitochondriale 
Afin d’élucider la nature des signaux de morts élicités par hFis1, nous avons 
opté pour une approche génétique et examiné l’effet de hFis1 dans des cellules 
Bax -/- Bak -/- Double Knock Out (DKO). Ces cellules sont résistantes à tous les 
stimuli apoptotiques intrinsèques testés à ce jour, ceux passant par 
l’oligomerisation de Bax et Bak et ceux élicités par le RE et le Ca2+. La 
surexpression de hFis1 dans les cellules DKO provoque la fragmentation des 
mitochondries, indiquant que Bax et Bak ne sont pas impliqués dans la fission 
mitochondriale. A l’inverse, nous n’avons pas observé d’apoptose dans les 
DKO après transfection de hFis1, ce qui implique que la fission des 
mitochondries n’est pas suffisante pour induire la mort cellulaire programmée. 
En outre nous avons confirmé que hFis1 induit un défaut mitochondrial latent 
dans les cellules contrôles, et montré que la perte du potentiel de membrane 
n’a pas lieu dans les DKO. La dissociation entre fission et apoptose a par 
ailleurs été confirmée par l’introduction d’une mutation dans le domaine 
intermembranaire de hFis1. 
 
hFis1 n’active pas directement Bax et Bak mais sollicite la voie du Ca2+ 
Bax et Bak semblant nécessaires à l’effet apoptotique de hFis1, nous avons 
testé l’activation de ces protéines in vivo et in vitro. Dans les deux cas, hFis1 
n’induit pas de changement conformationnel de Bax et Bak, suggérant  que 
d’autres voies d’activation de la mort cellulaire programmée sont sollicitées. 
L’utilisation de trois lignées cellulaires, les Bax -/- Bak -/- DKO, les Bax -/- Bak -/- 
DKO corrigées avec Bax, et les Bax -/- Bak -/- DKO corrigées avec SERCA, nous 
a permis de montrer que hFis1 n’a pas besoin des protéines proapoptotiques 
pour tuer, mais requiert au contraire la voie du Ca2+. Ceci est confirmé par 
l’observation qu’une diminution de la concentration de Ca2+ dans le réticulum 
endoplasmique  protège les cellules de la mort induite par hFis1.  
 
hFis1 sensibilise les mitochondries et favorise la transition de perméabilité 
Une augmentation excessive de Ca2+ dans le cytosol peut conduire à 
l’ouverture du PTP, conduisant à la perméabilisation des mitochondries et à 
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l’initiation de l’apoptose (Bernardi et al., 1999). Nous avons testé l’effet de hFis1 
sur l’ouverture du PTP, et observé que dans les cellules surexprimant hFis1, la 
concentration seuil de Ca2+ nécessaire à son ouverture est abaissée. 
L’utilisation d’inhibiteurs du PTP a d’autre part confirmé son importance dans la 
mort induite par hFis1. Cela signifie que les mitochondries sont fragilisées vis-à-
vis des stimuli de mort impliquant la voix du reticulum endoplasmique. La 
diminution du Ca2+ dans le réticulum endoplasmique pourrait ainsi constituer un 
mécanisme de protection vis à vis de ces signaux de mort.  
 
hFis1 n’affecte pas la respiration mitochondriale mais induit un remodelage de 
la structure interne des mitochondries 
La mesure directe de la respiration dans les mitochondries ne révèle pas de 
défaut majeur induit par hFis1, alors que les images de microscopie 
électronique révèlent une structure interne fortement perturbée. Il est possible 
que hFis1 induise une modification de la structure des cristae,  et favorise ainsi 
la libération, dans le cytosol, de facteurs apoptotiques. 
L’ensemble de ces résultats semble donc montrer que l’effet de hFis1 sur la 
survie cellulaire est dissocié de sa fonction dans la fission mitochondriale. La 
voie apoptotique sollicitée par hFis1 passe par l’ouverture du PTP, les 
mitochondries étant plus susceptibles d’être perméabilisées par les signaux 
calciques émanant du réticulum.  
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Chapter 1: Mitochondria and Cancer: Is there a 
morphological connection? 
 
Abstract 
Mitochondria are key players in several cellular functions including growth, 
division, energy metabolism, and apoptosis.The mitochondrial network 
undergoes constant remodelling and these morphological changes are of direct 
relevance for the role of this organelle in cell physiology. Mitochondrial 
dysfunction contributes to a number of human disorders and may aid cancer 
progression.Here, we summarize the recent contributions made in the field of 
mitochondrial dynamics and discuss their impact on our understanding of cell 
function and tumorigenesis. 
REVIEW
Mitochondria and cancer: is there a morphological connection?
E Alirol1 and JC Martinou
Department of Cell Biology, University of Geneva, Gene`ve, Switzerland
Mitochondria are key players in several cellular functions
including growth, division, energy metabolism, and
apoptosis. The mitochondrial network undergoes constant
remodelling and these morphological changes are of direct
relevance for the role of this organelle in cell physiology.
Mitochondrial dysfunction contributes to a number of
human disorders and may aid cancer progression. Here,
we summarize the recent contributions made in the ﬁeld of
mitochondrial dynamics and discuss their impact on our
understanding of cell function and tumorigenesis.
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Keywords: mitochondrial morphology; apoptosis;
energy metabolism; cancer
Introduction
Mitochondria play essential and diverse roles in the
physiology of eukaryotic cells. Not only do they provide
energy, but they also participate in numerous metabolic
reactions and play central roles in apoptosis (Desagher
and Martinou, 2000). Impairments of mitochondrial
functions have been implicated in a wide variety of
human pathologies, among which cancer and age-
related diseases (Wallace, 2005).
In the past years, a number of groups showed that
mitochondria are dynamic structures that undergo
fusion and ﬁssion events continuously throughout the
life of a cell (Okamoto and Shaw, 2005). Mounting
evidence indicate that mitochondrial dynamics have
roles beyond maintenance of morphology, and impact
on both cell death and cell metabolism (Chen and Chan,
2005). In mammals, mitochondrial fusion is driven by
two GTPases of the outer membrane named Mitofusins
1 and 2 (Mfn1, Mfn2) (Santel and Fuller, 2001; Chen
et al., 2003; Eura et al., 2003). The Mitofusins appear to
play distinct roles in fusion and the Mfn1 presumably
works together with Opa1, a GTPase of the inner
mitochondrial membrane (IMM) to promote fusion
(Cipolat et al., 2004). While its exact function remains
unclear, Opa1 seems also involved in further intra-
mitochondrial remodelling (Olichon et al., 2003).
Mitoﬁlin is another protein that has recently been
involved in cristae morphology (John et al., 2005).
Although models for mitochondrial fusion are still
incomplete, the mechanism proceeds through three
steps: docking, fusion of the outer mitochondrial
membrane (OMM) and fusion of the IMM. All three
steps involve GTP hydrolysis, and the IMM fusion
requires an intact membrane potential (Mattenberger
et al., 2003). Other players have been identiﬁed in yeast
but no mammalian homologs to them have been
described so far (Tieu and Nunnari, 2000).
The mitochondrial ﬁssion pathway involves at least
two proteins: dynamin related protein 1 (Drp1) and
Fis1. Drp1 is a cytosolic GTPase, which has been
proposed to couple GTP hydrolysis to membrane
constriction and ﬁssion (Smirnova et al., 2001). Fis1 is
an outer membrane protein evenly distributed on the
surface of mitochondria (James et al., 2003). It is
thought to recruit Drp1 to punctuate structures on
mitochondria and is thus considered as the limiting
factor in the ﬁssion process (Stojanovski et al., 2004).
The mechanism of constriction is not understood
but the current model postulates that Drp1 homo-
oligomerizes and forms a ring around the mitochon-
drial tubule (Okamoto and Shaw, 2005). Drp1 complexes
might generate mechanical force via conformational
changes, leading to membrane constriction, similar to
dynamin (Danino et al., 2004). Modiﬁcation of lipid
composition is likely to be involved, and additional
proteins may participate in mitochondrial ﬁssion. For
example, endophilin B1, a putative fatty acyl transfer-
ase, has been shown to act downstream of Drp1 in the
control of mitochondrial morphology (Karbowski et al.,
2004) and MTP18 is a novel mitochondrial protein that
is able to trigger mitochondrial fragmentation in a
Drp1-dependent fashion (Tondera et al., 2004).
GDPAP1, which is expressed in Schwann cells and
neurons, has also been reported to mediate mitochon-
drial ﬁssion (Niemann et al., 2005).
Membrane fusion and ﬁssion engage rupture and
deformation of lipid bilayers, and involve destabilized
monolayer intermediates (Chernomordik and Kozlov,
2003). The two membranes are ﬁrst brought in close
contact, then some hydrophobic monolayer discontinu-
ity appears that enables the rupture of the bilayer and
the formation of a fusion stalk intermediate. Successive
steps include the opening of a pore and its expansion,
connecting the two aqueous volumes (Kozlovsky et al.,
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2002). These processes involve speciﬁc proteins that
establish local intermembrane contacts and generate
local membrane stresses. Absence or excess of one of
these proteins could in theory result in failure of speciﬁc
steps and accumulation of intermediates.
As summarized in Table 1, disruption of the ﬁssion/
fusion machinery strongly alters organelle function
affecting both programmed cell death and energy
production. Several lines of evidence suggest that
mitochondria contribute to neoplastic transformation
by changing cellular energy capacities, increasing
mitochondrial oxidative stress and modulating apop-
tosis. A shift in the rate of mitochondrial ﬁssion or
fusion may provide new mechanistic explanation for the
aetiology of cancer, and may offer additional strategies
for therapeutic intervention.
Here, we discuss a possible role played by mitochon-
dria in oncogenesis and explore how misregulation of
ﬁssion and fusion machinery may inﬂuence apoptosis,
cell metabolism and tumour formation.
Mitochondrial apoptosis and its subversion in oncogenesis
The possibility that apoptosis is implicated in cancer
formation was ﬁrst raised in 1972 when Kerr et al.
(1972) described massive apoptosis in tumoural cell
populations. In the following years, the antiapoptotic
protein Bcl2 was shown to be a tumour-speciﬁc marker
which expression was enhanced in many lymphoma
(Tsujimoto et al., 1984; Bakhshi et al., 1985; Crescenzi
et al., 1988; Vaux et al., 1988; Nunez et al., 1990),
opening the investigation of apoptosis in cancer at the
molecular level. Suppression of apoptosis is among the
minimal requirements for a cell to become cancerous,
and a hallmark of most, if not all, types of cancer
(Hanahan and Weinberg, 2000; Green and Evan, 2002).
The inactivation of the p53 protein is the most common
strategy developed by tumour cells to evade apoptosis.
p53 is central in the DNA damage response and triggers
cell death by both transcription-dependent and
-independent mechanisms (Slee et al., 2004; Yee and
Vousden, 2005). Other examples of apoptosis evasion
include disruption of Fas death receptor pathway,
upregulation of the widespread antiapoptotic family of
inhibitors of apoptosis proteins (IAPs) or downregula-
tion of caspases (Muschen et al., 2000; Teitz et al., 2000;
Yang et al., 2003). The PI3K/Akt/ PTEN pathway was
also shown to play a role in abrogating apoptosis. Akt/
PKB is activated in a wide variety of cancers and this
activation leads to the phosphorylation of a number of
key apoptotic proteins thereby inactivating them (Testa
and Bellacosa, 2001).
Mitochondrial membrane permeabilization
Many death signals converge to mitochondria which
respond by releasing numerous proteins in the cytosol
(Patterson et al., 2000), among which several have
apoptogenic properties (e.g. cytochrome c, SMAC/
DIABLO, AIF, Endo G and Omi/HtrA2). In many cell
types mitochondrial membrane permeabilization
(MMP) is considered as the point of nonreturn in the
cell suicide (Ferri and Kroemer, 2001). However, in
sympathetic neurons for example, this event appears to
be reversible and death can be circumvented down-
stream of cytochromic c release (Martinou et al., 1999;
Deshmukh et al., 2000; Tolkovsky et al., 2002). Whether
it is also the case in cancer cells remains to be
determined. Upon release, cytochrome c triggers the
apoptosome formation and initiates the caspase cascade
Table 1 Proteins involved in mitochondrial fusion and ﬁssion and their effect on apoptosis and energy metabolism
Protein Function Localization Apoptosis Energy metabolism References
DRP-1 Fission cytosol
and OMM
Overexpression sensitizes cells
to apoptosis; silencing and
dominant negative mutant
reduce MMP induced by several
apoptotic stimuli
Breckenridge et al. (2003),
Frank et al. (2001),
Lee et al. (2004),
Szabadkai et al. (2004)
Fis1 Fission OMM Overexpression triggers MMP
and silencing protects from
several apoptotic stimuli
Overexpression
affects Dcm
James et al. (2003),
Lee et al. (2004),
Niemann et al. (2005);
Yu et al. (2005)
Endophilin B1 Fission Cytosol
and OMM
Silencing and dominant negative mutant
cause separation of OMM and IMM
Karbowski et al. (2004)
MTP18 Fission Mitochondria Silencing sensitizes cells to UV or
TNFa treatment.
Overexpression triggers MMP
Tondera et al. (2004)
GDPAP1 Fission OMM Niemann et al. (2005)
Mfns Fusion OMM Overexpression inhibits MMP
and Bax/Bak activation
Silencing affects Dcm and
respiration. Overexpression
of Mfn2 stimulates OXPHOS
Chen et al. (2005),
Pich et al. (2005),
Sugioka et al. (2004)
Opa1 Fusion IMM
and IMS
Silencing causes MMP and apoptosis
in Fis1 dependent fashion.
siRNA sensitizes cells to apoptotis
Affects Dcm and impairs
respiration
Chen et al. (2005),
Griparic et al. (2004),
Lee et al. (2004),
Olichon et al. (2003)
Mitoﬁlin Increases ROS production
and affects Dcm
John et al. (2005)
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(Nicholson, 1999). These killer proteases target many vital
proteins, committing the cell to death (Fischer et al., 2003).
Mitochondrial membrane permeabilization is regu-
lated by members of the Bcl2 family (Lucken-Ardjo-
mande and Martinou, 2005b). These proteins contain at
least one of the four conserved regions called Bcl2-
Homology domains (BH1-BH4). Antiapoptotic mem-
bers (e.g. Bcl2, Bcl-xL, Bcl-xW, Mcl-1 and A1/bﬂ-1)
display all four BH domains, proapoptotic members
(Bax, Bak and Bok/Mtd) lack BH4, and BH3-only
proapoptotic members (Bim/Bod, Bid, Bad, Bmf, Bik/
Nbk, Blk, Noxa, Puma/Bbc3 and Hrk/DP5) harbour
only BH3. Most of them also display a hydrophobic C
terminus that allow them to associate with membranes
(Schinzel et al., 2004). Heterodimerization of the Bcl2
family members seems crucial to the regulation of
MMP, and structural data has shown that antiapoptotic
proteins display an hydrophobic groove on their surface,
providing a binding site for the BH3 domain of the
proapoptotic members (Petros et al., 2004).
The exact mechanism leading to MMP is still unclear,
although several models have been proposed for this
process (Figure 1) (Martinou and Green, 2001; Cromp-
ton et al., 2002; Waterhouse et al., 2002). According to
Figure 1 Proposed mechanisms for mitochondrial membrane permeabilization (MMP). (a) Classic models involve either the
formation of channels by proapoptotic Bcl2-family members (e.g. Bax or Bak) or opening of the permeabilization transition pore
(PTP). Upon apoptosis induction, Bax/Bak undergo conformational changes and oligomerize to form large channels. Apoptotic
factors are then released from the mitochondrial inter membrane space (IMS) and cristae compartment into the cytosol where they
trigger caspase activation and cell death. Alternatively, death stimuli activate pathway that trigger PTP opening such as Ca2þ or
ceramide, allowing water and solutes to enter the mitochondrial matrix. Subsequent swelling of the organelle provokes the rupture of
outer mitochondrial membrane (OMM) and release of apoptogenic factors into the cytosol. (b) An alternative scenario could be that
during apoptosis, a membrane-perturbing agent (either tBid, Bax or a protein that controls mitochondria morphology) translocates to
the mitochondria and destabilizes the lipid bilayer. The recruitment of enzymes involved in lipids modiﬁcation, such as lysolipid
transferases (e.g. tBid or Endophilin B1) would enable the formation of a lipid pore and further intramitochondrial remodelling by
mitochondrial shaping proteins (e.g. Opa1 or Mitoﬁlin), triggering the release of apoptogenic factors. (c) Proposed model for
mitochondrial division process and ﬁssion induced MMP. Under normal conditions the ﬁssion machinery (Fis1, Drp1 and putative
proteins implicated in membrane perturbation and lipids modiﬁcations) is recruited and assembled on local foci on the OMM. IMM
and OMM are brought in close apposition to form a stalk intermediate. Under physiological division, Drp1 assembles into a ring and
constricts the mitochondria until it divides. Alternatively failure of mitochondrial ﬁssion machinery could result in bilayer
destabilization and lipid pore formation as previously shown. Apoptogenic factors would then be released in the cytosol.
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the ﬁrst model, the opening of a high-conductance
channel, the permeability transtition pore (PTP), would
cause loss of mitochondrial membrane potential (Dcm),
swelling of the organelle and rupture of the OMM as
solute and water enter the mitochondrial matrix (Hale-
strap et al., 2002). It should be noted that Dcm loss is
not sufﬁcient to prove PTP involvement, as many other
events can provoke it. Although the composition of the
PTP remains to be resolved, the prevalent hypothesis is
that it consists of three core proteins, namely the voltage
dependent anion channel (VDAC), the adenine nucleo-
tide translocase (ANT) and cyclophilin D (Halestrap
et al., 2002). The PTP is thought to open in response to
calcium and oxidative stress and Bcl2 family members
also seem to regulate its activity (Zamzami and
Kroemer, 2001). However, recent studies of mitochon-
drial permeabilization in ANT and Cyclophilin D
deﬁcient backgrounds tend to show that these proteins
are not obligatory components of the channel (Kokosz-
ka et al., 2004; Baines et al., 2005; Basso et al., 2005;
Nakagawa et al., 2005). Both proteins appear to be
regulators of the PTP opening as they inﬂuence its
sensitivity to Ca2þ .
An alternative model for MMP proposes that
proapoptotic Bcl2 family members oligomerize and
form channels within the OMM (Saito et al., 2000;
Epand et al., 2002b). This view is supported by the
similarity between these proteins and some pore-form-
ing bacterial toxins. Following a death signal, the
proapoptotic proteins Bax and Bak undergo a con-
formational change, and their N terminus becomes
exposed. Bax, which is usually in the cytosol or loosely
associated with mitochondria, translocates to the
mitochondria, oligomerizes and inserts in the OMM
causing MMP (Hsu et al., 1997; Desagher et al., 1999;
Antonsson et al., 2000). These events can be promoted
by tBid, the activated form of Bid, and inhibited by Bcl2
and Bcl-xL (Desagher et al., 1999; Eskes et al., 2000;
Cheng et al., 2001).
Mitochondrial membrane permeabilization generally
occurs in a concerted and rapid fashion, affecting most,
if not all, mitochondria in the dying cell. The classic
models mentioned above are far from being complete,
and theories on the molecular mechanism are formu-
lated, debated and modiﬁed on a regular basis (Lucken-
Ardjomande and Martinou, 2005a). Recent investiga-
tions revealed that during apoptosis, the mitochondrial
membrane properties are profoundly modiﬁed and the
mitochondrial network undergoes extensive fragmenta-
tion (Desagher and Martinou, 2000; Cristea and Degli
Esposti, 2004). Mitochondrial membrane permeabiliza-
tion requires drastic membrane remodelling, and both
lipids and components of the ﬁssion/fusion machinery
may participate in this process.
Importance of lipids and membrane topology
The ﬁrst insight into the role of membrane lipids in cell
death came from the observation that phosphatidyl-
serine (PS) became exposed at the cell surface during
apoptosis (Fadok et al., 1992). Subsequently several
studies revealed that apoptosis correlated with a
progressive proliferation of intracellular membranes
leading to the formation of apoptotic blebs. This was
in contrast to the process of necrosis, as apoptotic cells
disintegrate without leaking their intracellular contents
out in the medium, preventing the inﬂammatory
reactions that are induced by necrotic cells (Cristea
and Degli Esposti, 2004). Modiﬁcations of lipid
composition and bilayer curvature of the mitochondrial
membranes seem to be crucial for permeabilization.
Recent work has highlighted the importance of tBid,
which is able to insert into speciﬁc lysolipids of the
OMM (Esposti et al., 2001; Goonesinghe et al., 2005)
and to promote a negative membrane curvature of
synthetic lipidic membranes (Epand et al., 2002a). These
changes presumably prepare the ground for insertion
and oligomerization of Bax and Bak. tBid is also able to
modify IMM topology, as incubation of mouse liver
mitochondria with tBid induces a profound remodelling
of the cristae compartment (Scorrano et al., 2002).
Tomographic reconstructions revealed that the cristae
become more interconnected and that their junctions
widen concurring with enhanced mobilization of cyto-
chrome c. The molecular events leading to cristae
remodelling are not known. tBid could interact with
proteins of the IMM or could directly affect lipids to
modulate IMM topology. Indeed, tBid has been shown
to bind to cardiolipin, a negatively charged mitochon-
drial phospholipid present in the IMM (Lutter et al.,
2000; Liu et al., 2005). Recently, Kim et al. (2004)
reported that binding to cardiolipin is required for tBid
induced cristae remodelling and cytochrome c release.
Yet these rearrangements might not always be required
given the fact that Bid knockout mice do not display
particular deﬁcits in cell death and that Bid is not
expressed in all cells in vivo (Krajewska et al., 2002).
Other reports show that Bax destabilizes lipid bilayers
(Basanez et al., 1999; Epand et al., 2003) and interacts
with endophilin B1, a potential lysophosphatic acid
acyltransferase (Modregger et al., 2003). However, a
recent study suggests that the effect of endophilin B1
effect on membrane curvature could be an experimental
artefact (Gallop et al., 2005).
Lipid bilayer bending and tilt of hydrocarbon chains
can provide sufﬁcient lateral tension to drive pore
opening in a nonbilayer intermediate (Chernomordik
and Kozlov, 2003). This implies that membrane
permeabilization is not necessarily mediated by a
proteinaceous pore, but rather results from the con-
certed actions of proteins and particular lipids. As
illustrated in Figure 1, during apoptosis the formation
of discontinuity in the OM can lead to nonspeciﬁc
lipid pores. Thus Bax pore forming capacity could
be ascribed to membrane perturbation rather than
discrete channel activity (Cristea and Degli Esposti,
2004).
These observations shed a new light on the process of
mitochondrial membrane permeabilization, suggesting
that membrane topology is of direct relevance for
apoptosis. In addition, several investigations in the ﬁeld
of mitochondrial dynamics further strengthened the
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intimate relationship that exists between organelle
morphology and cell death.
Role of ﬁssion and fusion in apoptosis
As mentioned earlier, mitochondria undergo frequent
ﬁssion and fusion events that regulate their morphology.
During early stages of apoptosis, mitochondria undergo
massive fragmentation and it has been proposed that
changes in mitochondrial shape contribute to the
mitochondrial membrane permeabilization, perhaps by
setting free inter membrane space (IMS) proteins for
release (Frank et al., 2001; Karbowski et al., 2002; Reed
and Green, 2002; Lee et al., 2004). Both Drp1 and Fis1
have been implicated in this pathway (Perfettini et al.,
2005). Fis1 overexpression not only induces fragmenta-
tion of the mitochondrial network, but also leads to the
release of cytochrome c from the mitochondria caspase
activation and cell death (James et al., 2003). Silencing
of either Drp1 or Fis1 confers resistance to several
apoptotic stimuli and impairs cytochrome c release
suggesting that ﬁssion molecules are required for MMP
to occur (Frank et al., 2001; Karbowski et al., 2002;
Breckenridge et al., 2003; Lee et al., 2004; Germain
et al., 2005). However, translocation of Bax to the
mitochondria remains unaffected by ﬁssion inhibition,
suggesting that ﬁssion molecules act downstream of Bax
translocation. Mitochondrial fusion proteins also seem
to protect cells from apoptosis, as their overexpression
reduces cell death induced by several stimuli (Sugioka
et al., 2004), and their knocking down sensitizes cells to
apoptosis (Lee et al., 2004).
Several models exist to explain how mitochondrial
ﬁssion could participate in MMP. Karbowski et al.
(2004) reported that in addition to its role in apoptosis,
endophilin B1 regulates mitochondria morphology.
They also showed that upon apoptosis induction, Bax,
Drp1 and endophilin B1 translocate to Mfn2-containing
foci on the mitochondria (Karbowski et al., 2002, 2004).
The model they propose is the following: rather than
forming a ring around mitochondria, Drp1 would
mediate vesicle scission from focal regions around the
mitochondrial ﬁssion sites. This would allow the
removal of membrane by shearing away lipid vesicles
from OMM. One possible explanation for cytochrome c
release would be that Bax inserts preferentially in these
narrow curvature vesicles and permeabilize them.
Endophilin B1 could promote Bax insertion into
membranes through its membrane deformation activity
(Youle and Karbowski, 2005). However, the study from
Gallop et al. (2005) challenges this model as it shows
that endophilins are devoid of lysophosphatidic acid
acyl transferase activity.
Another model for the role of mitochondrial mor-
phology in apoptosis postulates that mitochondrial
shaping proteins could regulate cristae remodelling
and favour MMP (Germain et al., 2005; Scorrano,
2005). As mentioned earlier, rearrangements of the
cristae compartments is thought to increase the suscepti-
bility to apoptosis by enhancing the ability of mitochon-
dria to release cytochrome c (Scorrano et al., 2002).
Indeed, it seems that two pools of cytochrome c exist: a
minor soluble pool, which is present in the IMS and a
major pool conﬁned in the mitochondrial cristae and
which binds cardiolipin (Bernardi and Azzone, 1981; Ott
et al., 2002; Scorrano et al., 2002). Mitochondrial ﬁssion
is thought to be necessary for the release of the
membrane-attached pool of cytochrome c.
A role for ﬁssion and fusion molecules in this process
is supported by two observations. Firstly, loss of Opa1
expression has been reported to trigger apoptosis by
inducing such intramitochondrial remodelling (Olichon
et al., 2003). Secondly, Bik, a BH3-only protein present
on the ER, has been shown to induce Drp1-dependent
remodelling of the cristae compartment (Germain et al.,
2005).
However, there is still some controversy about the
role of mitochondrial ﬁssion in apoptosis and recent
work suggests that depending on the stimuli, ﬁssion can
also interfere with MMP (Szabadkai et al., 2004). The
biochemical and biophysical relationships between Bcl2
family members and the ﬁssion machinery remain to be
clariﬁed. The observation that these two classes of
proteins are responsible for membrane perturbation
and/or the release of proapoptotic factors does not
mean that they act in a concerted fashion. Moreover,
colocalization cannot account for functional interaction,
as local lipid bilayer properties directly affect the
recruitment, insertion and activity of proteins. It is,
therefore, crucial to determine the contribution of lipids
rearrangement to mitochondrial fragmentation both in
healthy and apoptotic cells. In addition, further
investigations are needed to determine what are the
molecular differences between physiological and death-
associated ﬁssion. Addressing these issues should help us
understand how mitochondrial fragmentation partici-
pates in programmed cell death and possibly correlates
with tumorigenesis.
Therapeutic perspectives
As impaired apoptosis plays a central role in oncogen-
esis, the search is accelerating for novel agents that
engage the cell death machinery (Nicholson,
2000; Johnstone et al., 2002). Impaired apoptosis is also
a signiﬁcant impediment to cytotoxic therapy. The
mutations that favour tumour development stiﬂe the
response to chemotherapy and radiation, and
treatment might select more refractory clones. Never-
theless, most tumour cells still remain sensitive to
some apoptotic stimuli, and most cytotoxic anticancer
drugs currently in clinical use induce apoptosis of
malignant cells (Don and Hogg, 2004). Therapeutic
approaches that enhance apoptosis include targeting of
Bcl-2 or the caspase inhibitors IAPs, or engaging the
death receptor pathway, by, for example, ligating
the receptors for TRAIL (Ashkenazi, 2002). Among
the recent strategies, the ones attempting to target
mitochondria and trigger MMP are very promising.
With much debate surrounding the components of the
PTP and its possible manipulation in cancer treatment,
many chemotherapeutics efforts have focused on target-
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ing the Bcl2 family (Oltersdorf et al., 2005). Other
cytotoxic drugs acting on mitochondrial lipids have been
shown to induce MMP in vitro and some are being
tested in preclinical mouse models (Don and Hogg,
2004). Recent ﬁndings on the role of mitochondrial
ﬁssion machinery in the MMP process may provide
additional possibility for the management of neoplastic
diseases.
Many scientists in the ﬁeld of cancer research may
have considered mitochondria only as a reservoir for
stocking harmful molecules such as ROS and apoptotic
proteins. However, several recent ﬁndings demonstrate
that mitochondrial participation in oncogenesis is far
from being restricted to apoptosis, and that mitochon-
drial energy production affects both cell proliferation
and tumour progression.
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Figure 2 Mitochondrial shape changes according to energy state. (a) Schematic representation of glucose metabolism. In the cytosol,
glucose is converted through glycolysis to pyruvate. Pyruvate is then either transformed to lactate via lactic fermentation, or
transported into the mitochondrial matrix where it enters the tricarboxylic acid (TCA) cycle. Electrons enter the electron transport
chain (ETC) via the NADH produced by the TCA cycle. Complexes I, III and IV couple electron transport to protons pumping. The
proton gradient generated is then used by ATP synthase to form ATP. (b) Different metabolic strategies are associated with different
mitochondrial morphology. In the case of the respirative phenotype, glucose is converted into pyruvate and further oxidized by
mitochondrial respiration (TCAþETC). The mitochondrial network appears interconnected and cristae compartment is enlarged. In
the case of glycolytic phenotype, the majority of cytosolic glucose is converted into lactate, leading to an acidiﬁcation of the
extracellular environment. Mitochondria appear fragmented and undergo matrix expansion.
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Mitochondrial physiology in cell proliferation and tumour
progression
Mitochondria produce ATP through oxidative
phosphorylation
In many cell types, cellular ATP is produced primarily
by the oxidation of glucose (Figure 2). This process can
be divided into two major steps. The ﬁrst, which takes
place in the cytosol, is glycolysis. In the absence of
oxygen, the end product of glycolysis, pyruvate, is
converted to lactic acid through cytosolic fermentation.
In the presence of oxygen, pyruvate is utilized by the
second step, which takes place in the mitochondria, and
includes the tricarboxylic acid (TCA) cycle and oxida-
tive phosphorylation (OXPHOS). Further oxidation of
pyruvate in the mitochondria leads to the production of
reducing equivalents (NADH and FADH2). These
compounds fuel the electron transport chain (ETC)
located in the IMM. The ETC is composed of four
multimeric complexes and couples the electron transport
to the extrusion of protons across the IMM. This
movement of protons creates an electrochemical gradi-
ent (Dcp¼DcmþDpH) across the IMM. Most of the
gradient is in the form of an electrical component, Dcm.
The charge separation across the IMM generates free
energy, which is utilized by the ATP synthase to
synthesize ATP. As a toxic by-product, OXPHOS
generates reactive oxygen species (ROS). ROS can act
both as tumour initiators, by inducing mutations in
proto-oncogenes and tumour-supressors, and tumour
promoters through enhancement of cell proliferation
(reviewed in Behrend et al., 2003; Wallace, 2005).
Impairment of the ETC very often results in excessive
ROS production and subsequent oxidative stress. It is,
therefore, crucial for the cell to keep watch over
mitochondrial respiration as it can turn into a hazar-
dous weapon when it fails.
Mitochondria modulate their shape according to their
bioenergetic activity
Substrate availability, and energetic state both modulate
the mitochondrial network (Figure 2). In the 1960s
Hackenbrock (1966, 1968a, b) reported that depending
on their respiration activity, the mitochondrial mor-
phology changed from an orthodox to a condensed
conformation. The condensed conformation, in which
mitochondria display large intracristae spaces, was
associated with state III respiration, when ADP is high
and OXPHOS activated. The orthodox conformation,
corresponding to an expanded matrix and a reduced
intracristae space, was observed under state IV. This
corresponds to low ADP and minimal O2 consumption.
Further evidence that mitochondria remodel according
to changes in OXPHOS activity came from the work of
Rossignol et al. (2004) who showed that the mitochon-
drial network extended within cells and became more
ramiﬁed and interconnected in the presence of galactose.
As previously mentioned, mitochondria shaping
proteins seem to affect energy production. A direct
connection between bioenergetics and mitochondrial
fusion machinery has recently been established. When
the balance is artiﬁcially tipped towards ﬁssion, an
energy defect emerges. Disruption of Mitofusins and/or
Opa1 results in severe cellular defects, including poor
cell growth, widespread heterogeneity of mitochondrial
membrane potential, and decreased cellular respiration
(Chen et al., 2005). Importantly, the respiration defect
turns out to be reversible upon reintroduction of the
wild-type fusion proteins. Another recent study reports
that downregulation of Mfn2 in L6E9 myotubes reduces
both the activity of the TCA and the ETC, while it
enhances glucose transport, glycolysis and lactic fer-
mentation (Pich et al., 2005). Conversely, the over-
expression of Mfn2 stimulates OXPHOS activity,
suggesting that its role is not limited to the control of
organelle shape. Mutations in Mfn2 have been ascribed
to Charcot–Marie–Tooth type 2A neuropathy, and
altered glucose oxidation could provide a mechanistic
explanation for the aetiology of the disease (Zuchner
et al., 2004). Silencing of Mitoﬁlin also affects metabolic
ﬂuxes (John et al., 2005).
Thus, it appears that mitochondrial morphology is
crucially linked to energy metabolism. Enhanced re-
spiration correlates with an interconnected network and
enlarged cristae compartment, whereas low OXPHOS
activity and high glycolysis correlates with smaller
mitochondria displaying reduced intracristae space. In
an extreme pathological situation, overfragmented
mitochondrial fail to run the ETC correctly, potentially
contributing to oxidative stress. On the contrary,
promoting fusion stimulates respiration. It is therefore
fundamental to maintain balanced mitochondrial ﬁssion
and fusion as its disruption could increase the suscept-
ibility to develop metabolic defects and consequent
diseases.
Altered energy metabolism is a hallmark of many types of
cancer
A curious but common property of invasive cancers is
altered glucose metabolism. Under aerobic conditions,
glycolysis is inhibited (the so-called Pasteur effect)
(Krebs, 1972) and normal mammalian cells rely mainly
on the mitochondrial OXPHOS for their energy supply.
However, cancer cells display a signiﬁcant increase in
glycolysis and lactate production even in the presence of
oxygen. This phenomenon, termed aerobic glycolysis
was ﬁrst described in 1956 by the German biochemist
and Nobel Laureate Otto Warburg (Warburg, 1956). He
postulated that cancer resulted from impaired mito-
chondrial metabolism. Although it turned out that
mitochondrial dysfunction is not the fundamental cause
of cancer, aerobic glycolysis certainly confers a growth
advantage to tumour cells (Gatenby and Gillies, 2004).
Firstly, it enables cancer cells to adapt to hypoxic
conditions as the premalignant lesion grows progres-
sively further from the blood supply. Secondly, the
glycolytic phenotype contributes to the acidiﬁcation of
tumour microenvironment, which facilitates tumour
invasion (Gatenby and Gawlinski, 1996; Schornack
and Gillies, 2003). This metabolic transition towards
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glycolysis is also seen in human cancer cell lines such as
Hela cells, in which minor amounts of glucose are prone
to the TCA cycle, the majority being converted to
lactate (Reitzer et al., 1979).
Mitochondria certainly have a role to play in this
metabolic shift, as their physiology is inextricably linked
to energy metabolism. Several groups reported that
tumour aggressiveness correlates with a low-mitochon-
drial respiratory chain activity, and that enhancement of
OXPHOS can reduce tumour growth (Hervouet et al.,
2005; Schulz et al., 2006). Furthermore, a number of
mitochondrial enzyme deﬁciencies are linked to inher-
ited neoplasia (Gottlieb and Tomlinson, 2005). These
include succinate deshdrogenase (SDH) genes SDHB,
SDHC, SDHD and fumarate hydratase (FH), which all
participate in the TCA cycle. In addition SDH is a
functional member (complex II) of the ETC. The
mechanism linking failure of the TCA cycle to tumour
development is not clear but two explanations have been
suggested so far. The ﬁrst hypothesis postulates that
SDH and FH deﬁciencies increase the production of
ROS (Messner and Imlay, 2002; Yankovskaya et al.,
2003). An alternative model proposes that succinate,
which accumulates due to TCA cycle impairment, acts
as a signalling molecule and triggers the activation of
hypoxia inducible factor 1a (HIF1a) (Selak et al., 2005).
Hypoxia inducible factor 1a promotes adaptation of
cells to low-oxygen consumption and activates the
transcription of glycolytic genes (Firth et al., 1995;
Semenza et al., 1996), stimulating aerobic glycolysis.
It seems thus that mitochondrial dysfunction favours
the emergence of the glycolytic phenotype, and that
after dwindling in importance for decades, Warburg’s
hypothesis is enjoying a resurrection. Although further
studies are required and warranted, induction of
mitochondrial respiration might be worth considering
as a mechanism to restrict tumour growth. The
energetic conversion towards aerobic glycolysis most
probably requires remodelling of mitochondria. As
OXPHOS activation seems to perturb malignant
transformation, it would be interesting to see whether
tumour metabolism is affected by the promotion of
mitochondrial fusion.
Mitochondrial ATP production and cell cycle progression
Another common property of cancers is a high
proliferation rate, which results both from cellular
growth and cell division. Although the energetic
requirements for cell cycle progression have not been
investigated thoroughly, it is highly probable that a
metabolic checkpoint exists. The status of cellular
energy stores is sensed by the AMP-activated protein
kinase (AMPK), which is activated upon ATP depletion
(Hardie, 2005). AMP-activated protein kinase has been
shown to inhibit mTOR and to coordinate G1-S
transition with carbon source availability (Kimura
et al., 2003; Jones et al., 2005). In mammals numerous
studies demonstrated that the G1-phase is associated
with an overall enhancement of mitochondrial function
(Van den Bogert et al., 1988; Leprat et al., 1990) and
that inhibiting mitochondrial function results in G1
arrest (van den Bogert et al., 1986, 1992; Heerdt et al.,
1997; King and Radicchi-Mastroianni, 2002; Gemin
et al., 2005). A recent study in Drosophila links a defect
in mitochondrial energy production to the activation of
AMPK (Mandal et al., 2005). Taken together this data
suggests the existence of an energy checkpoint at G1–S
transition controlled by the mitochondrial energy
production.
Interestingly the G1–S transition also correlates with
rearrangements of the mitochondrial network. Studies
in both ﬁbroblasts and osteosarcoma cells show that the
mitochondria become ﬁlamentous and highly intercon-
nected during the G1-phase while they appear fragmen-
ted in the S-phase (Barni et al., 1996; Margineantu et al.,
2002). This is consistent with the observation that
mitochondrial shape change according to energy state.
During the G1-phase the cell displays elongated
mitochondria correlating with increased OXPHOS
activity. This presumably enables efﬁcient energy
production in the expectation of S-phase, which requires
substantial amounts of ATP. At the end of the G1-phase
the cell evaluates its energy stocks, and takes the
decision either to pause and exit the cell cycle, or to
proceed toward the S-phase. However, maintaining a
high OXPHOS activity during DNA replication might
be dangerous, because of the deleterious effects of ROS
production. This could explain the decreased respiration
activity and the fragmented mitochondrial morphology
observed during the S-phase.
The proposal that according to energy requirements
cells modify their metabolism by remodelling the
mitochondrial network is challenging but still needs
experimental proof. Preliminary results show that
knockingdown components of the ﬁssion and fusion
machinery not only affects ATP production but also
impedes cell cycle progression ((Chen et al., 2005) and
Parone P and Martinou JC unpublished data). Along
with apoptosis resistance, hyper proliferation is a
common property shared by many cancers, and cell
cycle checkpoints are privileged targets of chemother-
apy. Future work will certainly address the importance
of mitochondrial network remodelling in energy pro-
duction, and establish whether these morphological
changes play a role in cell proliferation.
Conclusion and future perspectives
Over the past decades cancer research has generated a
rich and complex body of knowledge, revealing a
multitude of parameters that either cause or favour
malignant transformation. Several features, however,
emerge as essential requisites of tumourigenesis: apop-
tosis evasion, limitless cell proliferation, sustained
angiogenesis and tissue invasion are crucial properties
of cancers. Growing evidence show that mitochondria
are profoundly altered in transformed cells and partici-
pate in these processes. The study of cancer-associated
mitochondrial dysfunctions such as OXHOS impair-
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ment and apoptosis evasion has to take into account
their structural context, including the inﬂuence of
membrane topology on internal diffusion and compar-
timentation. Mitochondrial dynamics are gaining in-
creasing interest as it becomes indubitable that organelle
ﬁssion and fusion play a role in diverse biological
processes. Here, we have discussed the importance of
mitochondrial membrane remodelling in cell death and
energy metabolism, and its potential effect on tumor-
igenesis. Elucidating the molecular events that control
mitochondria dynamics will certainly give new insight
into organelle function in both normal and malignant
cells and will help to determine whether the changes in
organelle shape are meaningful for mitochondrial
contribution to oncogenesis.
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Chapter 2: hFis1, a role beyond mitochondrial 
fission? 
 
Abstract 
Mitochondrial morphology is maintained by opposing fusion and fission 
processes. Fission is achieved by two proteins in mammals: the cytosolic 
GTPase Drp1 and its Outer Membrane receptor hFis1. The regulation of hFis1 
activity and Drp1 recruitment still has to be determined. Moreover, the 
relationship between mitochondrial fission and other cellular processes is 
largely unknown. In this study we show that in addition to enhancing 
mitochondrial fission, hFis1 also generally impacts on cell physiology by 
affecting mitochondrial function and by triggering autophagy. Our mutational 
approach revealed that the N-terminal region of hFis1, and more specifically, 
the first α helix of the TPR fold, is crucial to mediate fission and to induce 
cellular toxicity. Moreover we have shown that hFis1 forms dimers both in vivo 
and in vitro, and that the C-terminus of hFis1 is required for this dimerization. 
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Introduction 
 
Mitochondria form an interconnected network 
In most eukaryotic cells, mitochondria form interconnected, tubular networks 
that continuously change shape and size. The constant remodelling of their 
morphology allows mitochondria to respond to changes in the environment and 
to adapt to cellular needs. Impairment of these dynamics has severe 
consequences on cell physiology and is associated with neurodegenerative 
diseases, obesity, and developmental lethality (Bossy-Wetzel et al., 2003; 
Chan, 2006). The budding yeast Saccharomyces cerevisiae has played a 
central role in the identification of proteins that regulate mitochondrial 
morphology; at least three pathways were shown to be involved, namely fusion, 
fission and tubulation (Okamoto and Shaw, 2005). Most proteins mediating 
opposing fusion and fission events are conserved in flies, worms, plants, mice, 
and humans while components of the tubulation pathway have not been 
identified in higher eukaryotes yet. 
 
Mitochondrial fusion in yeast and higher eukaryotes 
The first molecular regulator of mitochondrial fusion, Fzo (Fuzzy Onion), was 
identified in Drosophila melanogaster (Hales and Fuller, 1997), but direct 
demonstration of Fzo’s role came from a study of its yeast homologue 
(Hermann and Shaw, 1998). Yeast mutants lacking Fzo1p contain fragmented 
mitochondria, loose mtDNA and become respiration-deficient (Hermann and 
Shaw, 1998; Rapaport et al., 1998). Fzo/Fzo1p is a large GTPase localised on 
the Outer Mitochondrial Membrane (OMM), bearing two transmembrane 
domains on its C-terminus. In higher metazoa more than one Fzo-related gene 
has been found, and in human two different Fzo family members have been 
identified: Mitofusin 1 and 2 (Mfn1 and Mfn2) (Santel and Fuller, 2001). 
Overexpression of Mfn2 and Mfn1 induces extensive perinuclear clustering of 
mitochondria (Santel and Fuller, 2001; Rojo et al., 2002) while their knock down 
leads to a fragmented network (Chen et al., 2003;Ishihara et al., 2004). 
Mgm1/Opa1 is another GTPase, which is localized in the Inner Mitochondrial 
Membrane (IMM) and which also participates in fusion (Cipolat et al., 2004). 
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 Mitochondrial fission: players and proposed mechanism 
The fission proteins identified in yeast include Dnm1p, Fis1p, Mdv1p and Caf4p. 
Dnm1p (Otsuga et al., 1998; Bleazard et al., 1999; Sesaki and Jensen, 1999), 
and its mammalian homologue Drp1 (Dynamin Related Protein 1) (Smirnova et 
al., 1998; Pitts et al., 1999; Smirnova et al., 2001; Yoon et al., 2001) belong to a 
family of conserved GTPases. Dnm1p/Drp1 is found both in the cytosol and in 
punctate structures on the OMM that correspond to sites of mitochondrial 
division (Shaw and Nunnari, 2002; Osteryoung and Nunnari, 2003). Members of 
the dynamin family contain three functionally important and distinct domains: 
the GTPase domain, a smaller middle domain, and a C-terminal assembly or 
GTPase effector domain (GED). The association of these domains via intra- 
and inter-molecular interactions promotes the self-assembly of dynamins into 
higher order structures (Warnock and Schmid, 1996; Muhlberg et al., 1997; 
Smirnova et al., 1999; Marks et al., 2001; Yoon et al., 2001; Zhu et al., 
2004).The mechanism underlying Drp1–dependent membrane scission is still 
unclear, though probably similar to the endocytic process driven by dynamin 
(Hinshaw, 2000; Song and Schmid, 2003; Praefcke and McMahon, 2004). In 
vivo, self-assembly is required for dynamin's ability to remodel membranes 
during endocytosis (Song et al., 2004). In vitro, the assembly of dynamin on 
spherical lipid vesicles causes them to constrict and deform into dynamin–lipid 
tubes (Hinshaw and Schmid, 1995; Takei et al., 1998; Zhang and Hinshaw, 
2001; Chen et al., 2004). Based on these observations, dynamin has been 
postulated to play a mechanochemical role in severing endocytic vesicles from 
the plasma membrane (Hinshaw and Schmid, 1995; Marks et al., 2001; Song 
and Schmid, 2003). Dnm1p/Drp1 could act in the same way to constrict the 
mitochondria. Consistently, Dnm1p has been shown to form spirals which 
diameter corresponds to that of mitochondria constriction sites (Ingerman et al., 
2005). 
 
Fis1 is crucial for mitochondrial fission 
The assembly of Dnm1p/Drp1 complexes on mitochondria requires the 
membrane protein Fis1p (fission) in yeast (Mozdy et al., 2000) and hFis1 in 
humans (James et al., 2003; Stojanovski et al., 2004). In yeast the WD repeat 
adaptor proteins Mdv1p and Caf4p are also essential (Fekkes et al., 2000; Tieu 
and Nunnari, 2000; Cerveny et al., 2001; Tieu et al., 2002; Griffin et al., 2005). 
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Fis1p was first identified in yeast by genetic screening for mutants that restored 
w.t. phenotype in fusion deficient cells (Fekkes et al., 2000; Mozdy et al., 2000; 
Cerveny et al., 2001). The ΔFzo cells display fragmented mitochondria, loose 
mtDNA and are thus unable to grow on non-fermentable carbon source.  
Simultaneous deletion of Fzo and Fis1 reverts this growth defect and the 
mitochondrial network adopts a net-like morphology, showing that Fis1p is 
involved in the control of fission (Mozdy et al., 2000). The human hFis is 30% 
homologous to yeast Fis1p, and shares 96% of identity with bovine and mouse 
Fis1. Orthologues in Xenopus laevis, Caenorhabditis elegans and Drosophila 
melanogaster have been identified and display 73%, 41% and 42% of identity 
with hFis1 respectively. Fis1p/hFis1 is distributed evenly on mitochondria with 
its N-terminal domain exposed to the cytoplasm, and its C-terminus spanning 
the OMM and a short stretch of amino acids facing the Inter Membrane Space 
(IMS) (Figure 1). Fis1p/hFis1 is believed to mediate two separate steps during 
the division process (Tieu and Nunnari, 2000). Early in the fission pathway it 
regulates the recruitment of fission proteins to mitochondrial membrane, Fis1p–
Mdv1p and Fis1p–Caf4p complexes pre-assembly, and subsequent binding of 
Dnm1p (Tieu and Nunnari, 2000; Tieu et al., 2002; Griffin et al., 2005; Karren et 
al., 2005). Later at a rate-limiting step, Fis1p also participates in the actual 
fission process together with Dnm1p and Mdv1p (Shaw and Nunnari, 2002; 
Tieu et al., 2002; Cerveny and Jensen, 2003). 
 
Structure of hFis1 reveals a conserved TPR fold 
The protein structure of both yeast Fis1p (Suzuki et al., 2003) and human Fis1 
has been determined by X-ray crystallography and NMR spectroscopy (Dohm 
et al., 2004; Suzuki et al., 2005) (Figure 1B). hFis1 harbours a flexible 
unstructured N-terminal tail followed by an anti-parallel array of six α-helices 
(α1: Val11-Ala27; α2: Lys32-Val43; α3: Asn48-Leu62; α4: Lys67-Tyr83; α5: 
Tyr87-Thr100; α6: Asn105-Lys120), arranged in a Tetratrico Peptide Repeat 
(TPR)-like fold. In hFis1 the TPR-like fold forms a slightly curved core domain, 
with a concave hydrophobic surface. The C-terminus of hFis1 comprises a 
stretch of hydrophobic amino acids which constitute a predicted 
Transmembrane (TM) domain followed by positive residues (Lysines), a 
combination often found in proteins that are targeted to mitochondria 
(Wattenberg and Lithgow, 2001).  
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In yeast, the six α-helices of Fis1p form a TPR-like fold very similar to that of 
hFis1 (Suzuki et al., 2005). The major structural difference between the two 
proteins in solution is the structure of the N-terminal arm upstream of helix α1: 
The N-terminal arm of hFis1 is flexible, whereas the longer, N-terminal arm of 
yeast Fis1p folds back and binds to the hydrophobic pocket of the TPR motif 
(Suzuki et al., 2005). The role of this N-terminal arm is controversial, some data 
suggesting that it is essential for function (Suzuki et al., 2005), while another 
report suggests it only enhances the fission process (Karren et al., 2005). 
Intriguingly, when expressed in yeast, hFis1 fails to complement the 
mitochondrial morphology phenotype of Δfis1 cells (Stojanovski et al., 2004), 
suggesting that functional divergence has occurred during evolution. This 
difference could be explained in part by the structural data. 
Although the biological function of TPR-containing molecule differ, the TPR 
domains are known to mediate interactions and assembly of protein complexes 
(D'Andrea and Regan, 2003). The TPR-like folding of hFis1 cytosolic domain is 
similar to helix-rich proteins responsible for protein-protein interactions, 
including OMM import proteins Tom70 and Tom20 (Iwahashi et al., 1997; Chan 
et al., 2006; Wu and Sha, 2006). The hydrophobic groove found in the concave 
side of Fis1p/hFis1 could serve as a binding interface to target proteins of the 
fission machinery to mitochondria. In yeast Fis1p has been shown to interact 
with Dnm1p, Mdv1p and Caf4p, as well as with proteins involved in membrane 
targeting and translocation such as Hsp90 or Sec72 (Mozdy et al., 2000; Tieu et 
al., 2002; Griffin et al., 2005). Although hFis1 is suggested to have the same 
function as yeast Fis1p, it is currently unknown what human Fis1 recruits to 
mitochondria. A weak interaction with Drp1 has indeed been reported (Yoon et 
al., 2003), but no Mdv1p or Caf4p  orthologues were found in higher 
eukaryotes. Moreover the lack of complementation between yeast and 
mammalian Fis1 suggests that other binding partners and adaptors are 
involved.  
 
Aim of our Study 
To get more insight into the upstream signals regulating the constriction of the 
OMM, we decided to seek hFis1 interacting partners and to undertake a 
mutational analysis of the protein. Although we couldn’t detect any interaction 
with known fission and fusion molecules, we found that hFis1 homodimerizes 
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and that this dimerization requires an intact C-terminus. We also observed that 
hFis1 induced a growth delay, the formation of autophagosomes and triggered 
cell death, suggesting that fragmented mitochondria might be abnormal. Some 
of the results presented in this chapter are only partial, and several issues need 
additional investigations. Nevertheless, even incomplete data are informative 
and contribute to our understanding of hFis1 function. 
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Material and Methods 
 
Yeast strains and growth conditions  
Standard methods were used for growth and manipulation of yeast strains 
(Sherman, 1986; Gietz and Woods, 2002). Yeast were grown at 30°C, on rich 
(YP) or synthetic media (SD), in the presence of either a fermentable carbon 
source (Glucose), a fermentable carbon source that does not repress 
respiration enzymes (Galactose) or a non-fermentable carbon source 
(Glycerol). To assess the effect of hFis1 expression on growth, hFis1 was 
cloned into a low expression p426-CYC1 plasmid and a high expression p424-
ADH plasmid (Mumberg et al., 1995). To monitor growth in liquid media, 
overnight pre-cultures were diluted in fresh media to give OD600 0.1 and 
OD600 1. Cells were then grown at 30°C and OD was measured every hour. All 
strains used for microscopy and genetic studies were isogenic to BY4741, and 
PJ69-4A (James et al., 1996; Brachmann et al., 1998). Deletion strains Δfis1, 
Δdrp1 and Δfzo1 were obtained from EUROSCARF (Frankfurt, Germany).  
 
Yeast Two-Hybrid 
To test interactions between hFis1 and other proteins controlling mitochondrial 
morphology, yeast transformation and two-hybrid analysis were performed 
according to Agatep et al (Agatep, 1998) and to the instructions for the 
MATCHMAKER two-hybrid system (THS) (Clontech). hFis1, hFis1ΔTM, Mfn1 and 
Drp1 were cloned into the bait plasmid pGBDU and the fish plasmid pGAD. The 
PJ69-4A two-hybrid reporter strain was co-transformed with bait and fish 
plasmids and grown on SD lacking Uracyl and Leucine (SD-UL) to select for 
transformants. Interactions were assessed by growing transformants on SD-UL 
in the absence of Histidine (SD-ULH) and/or Adenine (SD-ULA). The 
pGBDUT7-T and the pGADT7-p53 were used as control for a positive 
interaction. Two identify hFis1 interacting partners, we co-transformed PJ69-4A 
with pGBDU-hFis1ΔTM and a mouse brain cDNA library (Clontech Cat number: 
ML400AH). Positives were selected on SD-ULH agar plates, and interaction 
strength was further tested on SD-ULHA agar plates and using the LacZ 
activation assay. Nucleic acids were extracted from yeast cells of each THS 
true positive by the phenol: chloroform method (Hoffman and Winston, 1987) 
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and after DNA extraction, electroporation of E.coli was performed as described 
(Dower et al., 1988).  Single clones were then sent for sequencing. 
 
Cell culture, Transfection and Reagents 
Mouse Embryonics Fibroblasts (MEFs) and Helas were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) plus 10% heat-inactivated fetal bovine serum 
(FBS), 2 mM L-glutamine, 50 units/ml penicillin, 0.5 mg/ml streptomycin and 
non essential amino acids and maintained in 5% CO2 at 37°C.  Tissue culture 
flasks were from Falcon and all cell culture reagents were obtained from 
Invitrogen. Transfection was performed using Transfectin Lipid Reagent 
(Biorad) following manufacturer instructions or using the CaPO4 protocol 
(Jordan et al., 1996). 
 
RNA interference 
shRNA against hFis1 and Drp1 were directly synthesized in cells using the 
recently developed Pretro vector (generously provided by Dr Agami and 
previously described in Brummelkamp et al 2002 cancer cell p243 ; 
Brummelkamp et al 2002 science p550 ). Nucleotides 219-238 and 429-447 of 
hFis1 (5’GTACAATGATGACATCCGTA3’ or 5’GGCCATGAAGAAAGATGGA3’) 
and nucleotides 294-312 and 515-534 of Drp1 
(5’GCAGAAGAATGGGGTAAAT3’ or 5’GGATATTGAGCTTCAAATCA3’) were 
chosen as target for RNAi. 
 
Live Cell Epifluorescence and Confocal imaging 
One day prior to transfection 4x105 cells were plated on 13 mm diameter glass 
coverslips (VWR). Cells were then transfected using a 1:2 ratio of target DNA to 
YFP–mito, RFP-mito or RFP-ER. 24 hours after transfection cells were 
incubated in Hank’s Balanced Salt Solution (HBSS) supplemented with 10 mM 
Hepes. For epifluorescence imaging, coverslips were placed on the stage of an 
Olympus IX inverted microscope equipped with a Xe-illumination system and a 
12-bit CCD camera (Till Photonics). For confocal images of mitochondrial 
network, green and red channel images were acquired simultaneously using 
two separate colour channels on the detector assembly of a Nikon Eclipse 
E600FN microscope equipped with a Biorad Radiance 2100 Confocal Laser 
Scanning system. 
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PEG Fusion Assay 
PEG assay was performed as described in (Cipolat et al., 2004). Three days 
before fusion, 1x107 MEFs were plated in T25 flasks. 48 hours before fusion, 
cells were co-transfected with RFP-mito/YFP-mito and the indicated plasmids. 
After 24 h, cells labelled with different fluorescent proteins were co-plated at a 
1:1 ratio onto 13-mm round coverslips. Fusion was then induced after 24 h by a 
60-sec treatment with a 50% (wt/v) solution of PEG 1500 (Sigma) in PBS, 
followed by extensive washes in DMEM supplemented with 10% FCS. To inhibit 
de novo synthesis of fluorescent proteins, 30 min before PEG treatment cells 
were incubated with the protein synthesis inhibitor cyclohexymide (20 µg/ml, 
Sigma), which was subsequently kept in all solutions and tissue culture media 
until cells were fixed for 30 min with ice-cold 4% (v/v) para-formaldehyde in 
PBS. After two washes with PBS, coverslips were mounted on slides with Anti-
Fade Reagent (Molecular Probes). 
 
Autophagy quantification 
One day prior to transfection 4x105 cells were plated on 13 mm diameter glass 
coverslips (VWR). Cells were then transfected using a 1:2 ratio of target DNA to 
YFP–LC3. 24 hours after transfection cells were incubated 30 minutes at 37°C 
in Hank’s Balanced Salt Solution (HBSS), 10 mM Hepes with or without 5.5 mM 
Glucose. Live cells were imaged as described before with an Olympus IX 
inverted microscope equipped with a Xe-illumination system and a 12-bit CCD 
camera (Till Photonics). Cell harbouring more than 2-3 YFP-LC3 vesicles were 
scored as autophagic. 
 
Analysis of Cell Death 
For analysis of apoptosis 6x104 MEFs were plates in 12-well plates and 
cotransfected 24 hours later with pEGFP and the indicated vector (Ratio 1:2). 
After 48 hrs cells were collected at the indicated times and then stained with 
Annexin-V-Alexa568 (Roche) according to the manufacturer protocol. Apoptosis 
was measured by flow cytometry (FACSCalibur, BD) as the percentage of 
Annexin-V positive events in the GFP positive population. 
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Subcellular Fractionation 
24 hours after transfection, Hela cells were harvested, resuspended in 
mitochondria buffer (70 mM Sucrose, 210 mM Mannitol, 10 mM Hepes pH 7.4) 
in the presence of Protease Inhibitors (Roche) and disrupted by dounce 
homogenisation. The homogenate was spun at 2000g for 5 minutes, the 
supernatant was recovered and recentrifuged 2000g for 5 minutes. The pellet 
containing cellular debris and nuclei was discarded. The supernatant was 
further centrifuged for 10 minutes at 13000g. The resulting pellet represented 
the mitochondrial fraction and was washed by an additional centrifugation for 10 
minutes at 13000g. The supernatant was further centrifuged at 100000g for 30 
minutes to pellet light membranes (LM), which included Endoplasmic Reticulum 
(ER) and peroxisomes. Protein concentration was determined by Bradford 
assay (Biorad). Rat liver mitochondria were isolated using a similar procedure. 
 
Gel filtration Analysis 
After transfection or after Staurosporine treatment, Hela cells were solubilized in 
Gel Filtration buffer (25mM Hepes/NaOH, pH7.5, 300mM NaCl, 2% (w/v) 
CHAPS) for 1 hour on ice. After solubilization, cells were centrifuged for 30 
minutes at 100000g and supernatant was loaded on the column. Gel filtrations 
were performed on a Superdex 200 (16/60) column from Amersham Pharmacia 
Biotech equilibrated in Gel Filtration Buffer at a flow rate of 1ml/min at 4°C. 
Fractions of 2ml were collected and analyzed by Western blotting using a 
monoclonal antibody directed against hFis1 or Drp1. 
 
Affinity chromatography on Ni–NTA–agarose.  
Rat liver mitochondria were isolated as described earlier, solubilized in Buffer A 
(300 mM NaCl, 25 mM Hepes, 20 mM Immidazole, 1mM PMSF, 1mM 
Benzamidine pH 8.0) + 4% CHAPS and centrifuged at 100000g. The 
supernatant was passed through a first Ni-NTA Agarose column to get rid of 
proteins that unspecifically bind Ni-NTA slurry. The flow through was then 
incubated overnight with or without rHis-hFis1 at 4°C in Buffer A + 1% CHAPS 
and applied to a second Ni-NTA Agarose 2.5 cm column equilibrated in buffer A 
+ 1% CHAPS. Subsequently, the column was washed with 5 ml buffer A + 1% 
CHAPS and proteins were eluted with 5 ml buffer A + 1% CHAPS containing 
300 mM imidazole. Fractions were precipitated with 80% TCA. 
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Immunoblotting 
Protein extracts were separated by SDS-PAGE (NuPAGE, Invitrogen), 
transferred onto PVDF membranes (Millipore) and probed using rabbit 
polyclonal anti-hFis1, rabbit polyclonal anti-Drp1 (BD Bioscience), anti-Prohibitin 
(Neomarker), anti Calnexin (SantaCruz) or anti LDH (SantaCruz). Horseradish 
peroxidase conjugated secondary antibodies (Amersham) were used followed 
by detection by chemiluminescence (Amersham). 
 
Ca2+ Measurements with targeted Aequorin 
Ca2+ concentration was measured following the method described in (Robert et 
al., 2000). 1x105 cells were plated on 13 mm diameter glass coverslips and co-
transfected 24 hours later, with mitochondrial (mtAeq) or ER Aequorin (erAeq) 
and control β-Gal or Myc-Fis1 plasmids. Two days after transfection, cells were 
washed with Kreb’s Buffer (125 mM NaCl, 5 mM KCl, 1 mM Na2PO4, 1mM 
MgSO4, 20 mM Hepes, 5.5 mM Glucose pH 7.4). For erAeq measurement, ER 
Ca2+ stores were first emptied by incubating cells 10 minutes at 37°C in Kreb’s 
Buffer + 1% FCS + 1mM EGTA +10 µM Ionomycin +100 µM 2,5-di-(tert-butyl)-
1,4 benzohydroquinone (tBuQH). Aequorin was then reconstituted for 3 hours in 
Kreb’s Buffer +1 mM N-AM-Coelenterazine (Molecular Probes) in the presence 
of 100 µM of tBuQH. For mtAeq measurement, cells were washed in Kreb’s 
Buffer and reconstituted for 1 hour in Kreb’s Buffer + 5 µM Native 
Coelenterazine (Molecular Probes). After reconstitution, cells were washed in 
Kreb’s Buffer +1mM EGTA +1%FCS and coverslips were placed in the 
luminometer chamber under perfusion with KRB/EGTA luminescence was 
measured with a luminometer. measurement and calibration were performed as 
described  
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Results and Discussion 
 
hFis1 triggers mitochondrial fission 
Cloning and characterization of the human homologue hFis1 revealed that the 
function of the protein in mitochondrial fission is conserved in higher organisms 
(James et al., 2003). Accordingly, when hFis1 is over-expressed in Mouse 
Embryonic Fibroblasts (MEFs), the mitochondria fragment into small dots and 
cluster around the nucleus (Figure 2A). In addition, consistent with the 
phenotype observed in ΔFis1 yeast, the silencing of hFis1 with RNAi leads to a 
slight elongation of the mitochondria (Figure 2A). However, the effect of hFis1 
silencing is not as drastic as the silencing of Drp1, suggesting that some 
residual fission still occurs in the absence of hFis1. Accordingly, the knocking 
down of hFis1 does not impinge on Drp1 distribution (Lee et al., 2004) and the 
yeast Dnm1p has been shown to spontaneously associate with liposomes in 
vitro (Ingerman et al., 2005). In addition, other proteins, like MTP18 or GDAP1, 
have been shown to drive fission independently from hFis1 (Niemann et al., 
2005; Tondera et al., 2005). It is therefore possible that in the absence of Fis1, 
Drp1 still targets to mitochondria and drives organelle scission.  
As the fragmented morphology observed upon hFis1 expression could result 
either from enhanced fission or from impaired fusion, we wondered whether 
hFis1 impinged on fusion. We thus performed a PEG-fusion assay on MEFs co-
transfected with hFis1 and mitochondrially targeted Red Fluorescent (mtRFP) or 
Green Fluorescent Proteins (mtGFP) (Cipolat et al., 2004). As shown in Figure 
3B and C, mitochondrial contents mix upon cell fusion, suggesting that hFis1 
expression does not interfere with mitochondrial fusion. The slight delay in 
mitochondrial merging could be due to the fact that content mixing between 
small round-shaped organelles is less efficient than between interconnected 
filaments. In addition we noticed that these dot-like mitochondria are much 
more mobile, running longer distances and moving faster, which could also 
decrease the probability of contact and fusion. Another possible explanation to 
this delay is that hFis1 indirectly affects fusion by perturbing Δψm, as fusion 
requires an intact membrane potential (Mattenberger et al., 2003). 
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The C-terminus of hFis1 is required for mitochondrial localization 
Immunofluorescence and proteinase K treatment showed that hFis1 localizes to 
the OMM (James et al., 2003).  Subcellular fractionation of MEFs confirms that 
endogenous hFis1 is found at the mitochondria (Figure 2B and C). As 
mentioned in the introduction, hFis1 contains a cytosolic N-terminus, a 
predicted TM domain and a short stretch of amino acids facing the IMS. To 
determine which region of hFis1 is important for function, we generated both C-
terminal and N-terminal deletion mutants. The removal of the TM and IMS 
domains of hFis1 results in a abnormal distribution of the protein, as revealed 
by both the Immunofluorescence analysis and subcellular fractionation of cells 
transfected with His-hFis1ΔTM (hFis1 lacking the C-terminus) (Figure 2B and C). 
This mistargeted His-hFis1ΔTM does not affect the morphology of the 
mitochondrial network (James et al., 2003). On the opposite, removal of N-
terminal portions of the molecule has no effect on mitochondrial localization 
(see chapter 3 Figure S1), but induces a morphology different from that 
triggered by wt hFis1 (Figure 3A). Whereas Myc-hFis1 induces the formation of 
punctate mitochondria, often clustered around the nucleus, the Myc-hFis1Δ1-32 
mutant produces a mixed phenotype, with elongated filaments in the distal parts 
of the cells and large spheres in the perinuclear region. These large organelles 
are also seen in the Myc-hFis1Δ1-48 mutant, and recall the morphology observed 
upon Mitofusin overexpression (Eura et al., 2003) or upon disruption of 
mitochondrial movement (Varadi et al., 2004). To address whether the N-
terminal deletion could behave as a dominant negative mutant, inhibiting the 
function of endogenous hFis1 and tipping the balance towards fusion, we 
looked at its behaviour in the PEG-fusion assay. Surprisingly, in cells 
expressing Myc-hFis1Δ1-32 mitochondrial fusion is impaired (Figure 3B and C), 
suggesting that fusion, as well as fission, is affected by the deletion of the α1. 
This coalesced morphology is also reminiscent of the one observed when 
anterograde movement of mitochondria on microtubules is inhibited (Varadi et 
al., 2004). We thus disrupted mitochondria association with the microtubules by 
pre-treating the cells with nocodazole. However this did not prevent the 
clustering induced by Myc-Fis1Δ1-32 (not shown). 
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hFis1 triggers autophagy and cell death in mammalian cells 
In addition to their role in the maintenance of mitochondrial morphology, several 
fission and fusion molecules are key regulators of cell death (Youle and 
Karbowski, 2005; Martinou and Youle, 2006). Permeabilization of the OMM is a 
crucial step in the course of cell death, and several observations report that 
tipping the balance towards fission enhances sensitivity towards death 
(Perfettini et al., 2005). Accordingly, hFis1 overexpression induces the release 
of cytochrome c and triggers a caspase-dependent death (James et al., 2003). 
As shown in Figure 4C, the expression of Myc-hFis1 in culture cells led to the 
onset of apoptosis and the exposure of phosphatidylserine at the plasma 
membrane. On the opposite, the N-terminus deletion mutants Myc-hFis1Δ1-32 
and Myc-hFis1Δ1-48 failed to induce cell death, suggesting that the N-terminal 
portion of the molecule is also required for hFis1 killing effect. This is in 
accordance with the report by Yu et al, who showed that removal of the N-
terminal helixes abolished hFis1-induced cytochrome c release (Yu et al., 
2005). The mechanism by which hFis1 triggers cell death has been investigated 
and is discussed extensively in chapter 3. 
Death induction by hFis1 is not as impressive as apoptosis induced by classic 
killing molecules such as Bax, the number of apoptotic cells never exceeding 
40% (Figure 4C). Moreover, apoptosis onset occurs 48 to 72 hours after 
transfection, much after mitochondria had fragmented.  We thus hypothesised 
that the majority of the cells were somehow protected against hFis1 induced 
death, and therefore decided to look at autophagy induction. 
Autophagy is an evolutionary conserved survival mechanism, which involves 
the bulk degradation of long-lived cytosolic proteins and damaged organelles 
(Yorimitsu and Klionsky, 2005). It is induced upon starvation and plays crucial 
role in several physiological processes such as cellular development and 
differentiation. There are at least three types of autophagy: macroautophagy, 
microautophagy and chaperone-mediated autophagy. Macroautophagy is a 
multi-step process by which portions of the cytoplasm and organelles are 
sequestered in double or multi-membrane structures known as 
autophagosomes, and delivered to lysosomes for degradation. Two connected 
signaling pathways encompassing class-I phosphatidylinositol 3-kinase (PI3K) 
and mammalian target of rapamycin (mTOR) play a central role in controlling 
macroautophagy. Although specific molecular targets have not been identified, 
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increasing evidences suggest that autophagy preferentially removes damaged 
organelles (Rodriguez-Enriquez et al., 2004). In yeast, mutants that are unable 
to maintain their Δψm show increased rate of autophagy (Priault et al., 2005), 
and in mammalian cells, confocal imaging studies have demonstrated that 
mitochondrial depolarization precedes mitochondrial autophagy in hepatocytes, 
(Elmore et al., 2001).  
To investigate autophagosomes formation, we used a yellow fluorescent protein 
(YFP) tagged to the light-chain 3 (LC3). During autophagy, LC3 becomes 
cleaved and concentrates in autophagosomes, the fluorescence signal 
produced by YFP−LC3 changing from cytosolic to vesicular (Kabeya et al., 
2000). In parallel we also assessed mitochondrial membrane potential (Δψm) by 
loading hFis1 overexpressing MEFs with the potentiometric dye tetramethyl 
rhodamine methylester (TMRM). As shown in Figure 4 A, punctate localization 
of YFP−LC3 is observed in cells expressing Myc-Fis1, indicating the onset of 
autophagy. A decrease of TMRM fluorescence is also detected in some 
transfected cells. These results suggest that hFis1 overexpressing cells display 
abnormal mitochondria, which could be removed by autophagy.  
Interestingly, the Myc-hFis1Δ1-32 mutant induced YFP-LC3 staining of 
autophagosomes as efficiently as full length Myc-Fis1, while it failed to induce 
death (Figure 4 B and C). This N-terminal deletion mutant will certainly prove 
useful to study autophagy induction by hFis1. It would also be interesting to 
determine and compare the kinetics of autophagosomes formation in both Myc-
Fis1Δ1-32 and Myc-Fis1 transfected cells. A faster apparition of autophagosomes 
in the Myc-Fis1Δ1-32 mutant could explain the apparent incompetence of 
mitochondria to fuse described previously in the in vitro assay. 
 
Cells overexpressing hFis1 display reduced [Ca2+]ER  
hFis1 and Drp1 has been shown to regulate peroxisome as well as 
mitochondrial fission (Koch et al., 2003; Koch et al., 2005), and it is tempting to 
think that a common set of proteins control the morphology of several 
organelles, including the ER. As overexpression of hFis1 leads to a massive 
mitochondrial fragmentation, we wondered whether it also has an effect on the 
architecture of the ER. We thus co-transfected MEFs with Myc-Fis1 and ER-
RFP and fluorescence was visualized by confocal microscopy (Figure 5A). 
While the mitochondrial network readily fragments upon hFis1 expression, we 
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could not detect any morphological changes in the ER following Myc-Fis1 
transfection, even at late time points. Thus, different machineries may regulate 
the morphology of the two organelles. 
Mitochondria play crucial roles in Ca2+ homeostasis as they buffer cytosolic Ca2+ 
increases, contribute to ER stores refilling and participate in the CCE pathway 
by conveying the Ca2+ entering from the plasma membrane (Arnaudeau et al., 
2001; Malli et al., 2003). Because of the low Ca2+ affinity of the mitochondrial 
uniporter, high Ca2+ concentrations are needed for efficient mitochondrial 
uptake. Such high concentrations could be generated at close contact between 
mitochondria and Ca2+ channels at the plasma membrane or at the ER (Rizzuto 
et al., 1998). Altering the morphology of the mitochondrial network could in 
theory disrupt these contacts and affect the ability of mitochondria to regulate 
Ca2+ fluxes. Since hFis1 triggers such a dramatic morphological change of 
mitochondria, we reasoned that it could also impact on the crosstalk between 
the two organelles and affects Ca2+ homeostasis. Using differentially targeted 
aequorins, we measured steady-state mitochondrial and ER Ca2+ contents as 
described in (Robert et al., 2000). We found that expression of hFis1 does not 
affect mitochondrial Ca2+ contents (not shown), consistent with previous reports 
(Frieden et al., 2004; Frieden et al., 2005). However, hFis1 overexpressing cells 
have reduced [Ca2+]ER, the rate and extent of ER refilling displaying a ~40% 
decrease (Figure 5B and C). Reduced [Ca2+]ER is in line with the decreased 
CCE observed in the study mentioned above (Frieden et al., 2004), as CCE 
dictates Ca2+ refilling of the ER (Jaconi et al., 1997).  
Although we do not know whether contact sites are dismantled in hFis1 
overexpressing cells, these results indicate that mitochondria probably remain 
embedded in the ER network and the Ca2+ crosstalk between the two 
organelles does not seem to be affected. The effect on [Ca2+]ER is most likely 
indirect, as the ER morphology remains unaffected and as hFis1 has never 
been reported to localize at the ER. Frieden et al provide an interesting 
explanation, which suggests that the transfer of Ca2+ from plasma membrane 
channels to the ER is impaired due to the absence of mitochondria in the 
subplasmalemmal region of the cell. Indeed, hFis1 triggers clustering of 
mitochondria around the nucleus, and leaves entire regions devoid of 
mitochondria, which implies that the cell is much more sensitive to variations in 
the extracellular Ca2+ concentration (Frieden et al., 2005). It seems therefore 
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that hFis1 not only impedes on mitochondrial function, but also indirectly 
influences Calcium homeostasis. 
 
hFis1 interacting partners  
hFis1 is considered as a limiting factor in mitochondrial fission (Stojanovski et 
al., 2004) and likely represents the focal point for the regulation of the process, 
linking upstream elements to the constriction of the OMM. To get more insights 
into those questions we decided to seek hFis1 interacting partners and tested, 
in the Two-Hybrid System (THS), a set of potential binding partners involved in 
the control of mitochondrial dynamics. As shown in Figure 6A, we failed to 
detect any interaction with known fission and fusion proteins and could not 
confirm in our system the biochemical interaction reported by Yoon et al 
between Drp1 and Fis1. This suggests that, as it is the case in yeast, additional 
proteins might be needed to mediate this interaction (Tieu et al., 2002; Cerveny 
and Jensen, 2003; Griffin et al., 2005). Interestingly, we found that hFis1 
interacts with itself and that this interaction requires an intact C-terminus, 
suggesting that the TM and IMS domains are involved in this interaction. We 
also found that Drp1 self interacts, which is consistent with a previous study 
(Zhu et al., 2004).  
As already mentioned, no Mdv1p or Caf4p are found in higher eukaryotes, and 
other binding partners and adaptors remain to be identified in mammals. We 
therefore undertook a Gal4-based yeast Two-Hybrid Screen (THS). To avoid 
targeting of our Gal4-Fis1 fusion protein to membranes, the truncated version of 
hFis1, hFis1ΔTM, was fused to Gal4 and screened against a mouse brain library. 
Positive clones were selected, and interactions were confirmed before clone 
sequencing. Figure 6B shows a list of proteins that consistently displayed 
interaction with hFis1ΔTM. Several enzymes involved in energy metabolism as 
well as Ca2+ binding proteins are present in this list. Calmodulin is known to 
regulate the activity of a large number of enzymes, in particular kinases and 
phosphatases. Reticulocalbin-3 is a member of the CREC family and is found in 
the secretory pathway (Honore and Vorum, 2000). SLC25A is a mitochondrial 
Ca2+ binding Aspartate/Glutamate carrier which plays an essential role in 
transduction of Ca2+ signals to mitochondria in neuronal cells (Pardo et al., 
2006) as well as glucose metabolism and mitochondrial activity in beta cells 
(Rubi et al., 2004). We also found two enzymes involved in energy metabolism: 
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the Succinate Dehydrogenase subunit A contributes to both TCA cycle and 
respiratory chain, and α-enolase participates in glycolysis. While these results 
only represent in vitro interactions, they suggest that hFis1 impacts on Ca2+ 
homeostasis and mitochondrial function.  
After clone isolation and sequencing, we encountered difficulties in the 
reconstruction of the two-hybrid positives. The retransformation of Gal4-
hFis1ΔTM with the isolated cDNA resulted in a severe toxicity, cells displaying 
poor growth on SD. A possible explanation is that the positive clones initially 
contained not one but two fish plasmids, one interacted with hFis1, while the 
other counteracted the toxicity of hFis1. The clone isolation procedure enables 
the purification of only one fish plasmid, hence it is possible that the plasmid 
counteracting hFis1 toxicity was lost. Therefore, the interactions listed in Figure 
6B need to be reassessed by other means.  
To get more insights into hFis1 induced toxicity and to address whether the 
growth defect resulted from the nuclear targeting of the GAL4- hFis1ΔTM fusion 
protein, we subcloned hFis1 in both a low and a high expression vector and 
assessed growth of transformants on different carbon sources. When yeasts 
are grown on glucose, the genes involved in respiration are inhibited by a 
process called glucose repression, and cells retrieve their energy from 
fermentation. Concomitantly, the mitochondrial network adopts a rather simple 
structure (Hoffmann and Avers, 1973; Visser et al., 1995; Egner et al., 2002; 
Rolland et al., 2002). If Galactose is the carbon source, respiration genes are 
no longer inhibited, and ATP is generated by both fermentation and 
mitochondrial oxidative phosphorylation, Finally, the use of a non-fermentable 
carbon source such as Glycerol forces cells to use mitochondrial respiration. In 
the absence of glucose repression, the mitochondrial network appears highly 
branched and mitochondrial tubules are narrow (Hoffmann and Avers, 1973; 
Visser et al., 1995; Egner et al., 2002; Rolland et al., 2002). As shown in Figure 
7A, the toxicity induced by hFis1 was more pronounced on Galactose and 
Glycerol Agar plates. In liquid synthetic media, the growth defect was readily 
detectable in glucose, and we couldn’t obtain any growth when glycerol or 
galactose were used (Figure 7B). This indicates that hFis1 may trigger a 
mitochondrial dysfunction in yeast, the consequences depending on the carbon 
source and the requirement for functional mitochondria. The defect observed 
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was proportional to hFis1 expression, and was more pronounced in the PJ694A 
Two-Hybrid strain (Figure 7B).  
Excess mitochondrial fragmentation in yeast is known to lead to respiration 
deficiency, loss of mtDNA and a so-called petite phenotype (Scott et al., 2003). 
However, transformation of hFis1 did not lead to the formation of petite cells, 
but rather to a generalized growth defect and a delay in generation time. In 
addition, the expression of hFis1 in yeast did not trigger mitochondrial fission 
and failed to complement the mitochondrial morphology defect observed in 
ΔFis1 cells (See Figure S1). Taken together, these data suggest that the toxicity 
we observe in yeast is not linked to an excess of fragmentation. It would be 
interesting to investigate whether the toxicity in yeast is also associated with 
drop in Δψm, altered Ca2+ homeostasis and /or enhanced autophagy.  
 
hFis1 forms dimers both in vivo and in vitro 
Fis1 is thought to regulate the assembly of a mitochondrial division complex. 
We therefore turned to Gel filtration chromatography to try to purify this high 
molecular weight complex. Hela cells were transfected with HA-Fis1 or HA-
Fis1ΔTM and 24 hours later total cell extracts were loaded on a Superdex 200 
column. As shown in Figure 8A and B, endogenous as well as HA-Fis1 were 
eluted in fractions comprised between 21 and 61 kd, although hFis1 predicted 
size is 17 kd. Conversely, HA-Fis1ΔTM was found in fractions corresponding to 
15-20 kd, which is in agreement with its expected size. This indicates that full 
length hFis1, but not Fis1ΔTM, either binds to an unknown factor or oligomerizes. 
In parallel we also loaded the recombinant rHis-Fis1 protein onto the Superdex 
200, and found that the elution profile was undistinguishable from the hFis1 
expressed in mammalian cells (not shown). The truncated recombinant protein 
rHis-Fis1ΔTM also co-eluted with the 15 kd protein marker. These results confirm 
what was obtained in the THS and suggest that hFis1 dimerizes, both in vivo 
and in vitro, this dimerization requiring an intact TM domain. As Drp1 has been 
reported to associate with Fis1 (Yoon et al., 2003), we also looked at its elution 
profile. We could not find Drp1 in the same fractions as hFis1, but as shown in 
Figure 9C, detected it in fractions corresponding to 300 kd. Accordingly, Drp1 
has been reported to form tetramers in vivo (Zhu et al., 2004) and dimers of 
hFis1 have been observed in vitro (Dohm et al., 2004). It could be that the 
interaction between Drp1 and hFis1 is easily disrupted or too weak to be 
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detected by gel filtration. The ability of Drp1 to form tetramers did not require a 
functional GTPase domain, as the dominant negative Drp1K38A mutant elutes at 
the same high molecular weight fraction (Figure 8D). Similarly, the addition of 
GTPγS had no effect. This is consistent with the study by Zhu et al who 
reported that impaired GTPase activity does not affect tetramer formation (Zhu 
et al., 2004). 
The formation of the mitochondrial division complex might be transient or labile, 
rendering it difficult to purify in normal cells, where fission and fusion events 
occur continuously.  We reasoned that tipping the balance towards fission 
would increase the amount of assembled complex, and we thus induced 
massive mitochondrial fragmentation by treating cells with the protonophore 
FCCP or the death stimulus Staurosporine (STS) prior to extraction and gel 
filtration analysis. However, even under these conditions we were not able to 
detect any changes in hFis1 or Drp1 elution profile (not shown). 
In yeast, though the morphology of ΔDnm1 and ΔFis1 is undistinguishable, 
Fis1p is not visualized in punctate fission complexes along with Dnm1p and 
Mdv1p (Mozdy et al., 2000; Tieu et al., 2002; Karren et al., 2005). This finding 
raises the possibility that Fis1p physically interacts with the fission complex 
components before but not after their assembly into punctate fission complexes.  
It is also possible that other crucial factors are lost during purification of 
mitochondria. De Vos and co workers have shown that disruption of F-actin 
attenuates fission and Drp1 recruitment (De Vos et al., 2005). Microtubule 
seems also important for the recruitment of Drp1 on mitochondria (Varadi et al., 
2004). These cytoskeletal components might be lost during purification and thus 
affect the pattern of protein-protein interaction and complex assembly. 
As the expression of hFis1 triggers toxicity in both yeast and mammalian cells, 
we turned to an in vitro method, Affinity Chromatography, to try identifying 
proteins that bind to Fis1. Purified mitochondrial proteins were incubated with 
the recombinant rHis-FisΔTM and complexes were captured by incubation with 
Nickel-NTA Agarose. Bound proteins were subsequently eluted and separated 
by SDS electrophoresis, and after silver staining, band patterns were 
compared. By using this approach we were able to detect several bands 
specific to the fraction containing rHis-FisΔTM, two of which are shown in Figure 
9A. Protein sequencing revealed that these two bands corresponded to 
mitochondrial Hsp70 (SwissProt Accession # P48721) and Long Chain Fatty 
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Acid CoA Ligase (SwissProt Accession # P18163) respectively. TPR folds are 
known to mediate protein-protein interactions, and several chaperones and 
protein assembly factors interact trough these motifs (D'Andrea and Regan, 
2003). Database searches for THS interactions revealed that Fis1p interacts 
with Hsp90, Sec72 and Jsn1, however these interactions might not be specific, 
as none of these proteins is found at the mitochondria. As we were not able to 
co-Immunoprecipitate hFis1 and Grp75, we conclude that this interaction may 
not be physiologically relevant. hFis1 also interacted with Long- Chain Fatty 
Acid CoA ligase. This enzyme is found both on mitochondria and peroxisomes, 
and is central in lipid β-oxidation. The interaction with the Long- Chain Fatty 
Acid CoA ligase is still under investigation and future studies shall determine 
whether it is physiologically relevant. 
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Conclusion 
 
Although initially aimed at identifying hFis1 interacting partners, our study 
proved to be useful for the functional analysis of hFis1 and suggests that hFis1 
has a role beyond the control mitochondrial fission.  We found that in yeast as 
in mammals, hFis1 is toxic, most probably as a consequence of a mitochondrial 
dysfunction. In addition, we provide evidence that hFis1 forms dimers both in 
vivo and in vitro, and that dimerization requires an intact C-terminus. Whether 
these dimers are important for hFis1 function still has to be determined. The 
outcomes of hFis1-induced mitochondrial defect are altered Ca2+ homeostasis, 
increased autophagy and cell death. Several results indicate that this toxicity 
might not be directly linked to excessive fragmentation. Consistently, Nietmann 
et al identified a neuronal-specific mitochondrial fission protein, named GDAP1 
(Ganglioside-induced Differentiation Associated Protein 1), which fragments 
mitochondria without affecting organelle’s Δψm and without triggering death 
(Niemann et al., 2005). Thus fission might not be sufficient to induce death, and 
additional roles of hFis1 might be required for cell killing. Future studies will 
address the role of apoptotic factors, Ca2+ and mitochondrial dysfunction in the 
apoptotic signals invoked by hFis1.  
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Figures 
 
Figure 1 hFis1 sequence and structure 
(A) Alignement of the human hFis1 (Q9Y3D6) with the orthologs from Bos 
Taurus (Q3T0I5), Mus musculus (Q9CQ92), Xenopus laevis (Q3B8D8), 
Caenorhabditis elegans (Q19383), Drosophila melanogaster (Q8SYX2) and 
Saccharomyces cerevisiae (P40515). Sequences were obtained from Swissprot 
database and aligned with Clustall W tool (EBI, Hinxton, UK). (B) Structure of 
hFis1 and of predicted structure of the mutants used in this study. The N-
terminal part of the molecule is composed of 6 helixes (α1: red; α2: yellow; α3: 
green; α4: pink; α5: blue; α6: cyan) arranged in a TPR fold and followed by a 
transmembrane (TM: Gly 122-Gly 144: orange) and a short Intermembrane 
Space (IMS) domain. Mutants lacking the first α helix (Fis1Δ1-32), the first and 
second α helix (Fis1Δ1-48), and the C-terminus (Fis1ΔTM) are shown on the right. 
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Figure 2 hFis1 controls mitochondrial morphology 
(A) Expression levels of hFis1 control mitochondrial network morphology. 
Representative images of MEFs co-transfected with mtRFP and either with 
Myc-Fis1 or with Fis1 or Drp1 RNAi. Excess of hFis1 triggered fragmentation 
while absence of hFis1 resulted in elongation. Scale Bar 15 µM. (B) The C-
terminus domain of hFis1 is required for mitochondrial localization. 
Representative images of MEFs transfected with either His-Fis1 or His-Fis1ΔTM, 
and stained with an α-His antibody. His-Fis1 localizes to mitochondria while the 
His-Fis1ΔTM construct does not. (C) Subcellular fractionation of MEFs 
transfected with His-Fis1. 24 hours after transfection lysed and subcellular 
fractionation was performed as described to produce cytosolic and 
mitochondrial (mito) fractions. Endogenous hFis1 localized to mitochondria 
while a mutant lacking the transmembrane domain (His-FisΔTM) remained 
cytosolic. 
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Figure 3 The N-terminal region of hFis1 is important for the maintenance 
of mitochondrial morphology 
(A) The N-terminus of hFis1 is essential for fission. Representative images of 
MEFs co-transfected with mtRFP and wt (Myc-Fis1) or mutants lacking the first 
α helix (Myc-Fis1 Δ1-32) or the first and second α helixes (Myc-Fis1 Δ1-48). 
Expression of the mutants resulted in perinuclear aggregation of mitochondria. 
Bar 15 µM. (B) hFis1 does not interfere with fusion while Myc-Fis1 Δ1-32 does. 
Representative images of hetero polykaryons after PEG-induced cell fusion. 
MEFs were co-transfected with mtYFP or mtRFP, and control plasmid (β-gal), 
Myc-Fis1, or Myc-Fis1 Δ1-32 , coplated, fused and fixed. Confocal images of 
representative polykaryons are shown. (Scale bar, 20 µm.) (C) Quantification of 
the effects of wt and mutants of hFis1 on mitochondrial PEG fusion assay. 
Experiments were carried out as previously, and cells were fixed at the 
indicated times. Mitochondrial fusion was evaluated as described in 
Experimental Procedures from 30 randomly selected polykaryons. Data 
represent mean ± SE of 3 different experiments. 
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Figure 4 hFis1 induces autophagy in MEFs 
(A) Representative images of MEFs co-transfected with YFP-LC3 and with 
control (β-gal) or Myc-Fis1, washed 24 hours later and incubated with the 
potentiometric dye TMRM for 30 minutes in the absence (starved) or presence 
(Ctrl) of glucose. Live cell fluorescence was imaged using a confocal 
microscope and representative images were acquired. (B) Quantification of cells 
displaying YFP-positive autophosomes. MEFs were treated as in (A) and 
counted for vesicular versus cytosolic YFP-LC3 pattern. Data represent mean ± 
SE of 3 different experiments (C) hFis1 induces apoptosis in MEFs. wt MEFs 
were cotransfected with GFP and the indicated plasmids. Apoptosis was 
determined as the percentage of GFP positive, Annexin-V positive cells by flow 
cytometry. Data represent mean±SE of 6 different experiments. 
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Figure 5 MEFs expressing hFis1 display reduced [Ca2+]ER 
(A) hFis1 does not affect ER morphology. Representative images of MEFs co-
transfected with erRFP and control (β-Gal) or Myc-Fis1. (B) Representative 
recording of [Ca2+]ER measured with ER-targeted Aequorin. Cells in which ER 
Ca2+ was depleted were perfused as indicated with high-Ca2+ buffer (1 mM 
Ca2+) to allow refilling of intracellular stores. Where indicated the SERCA pump 
inhibitor tBuQH was added to block ER Ca2+ uptake. (C) MEFs were co-
transfected with a control protein (β-Gal) or Myc-Fis1 with erAEQ and [Ca2+]ER 
was measured as in (B). Data are means ± SE of 15 different experiments 
(steady-state [Ca2+]ER   for control cells is 254.13 µM ± 24.35 and 156,24 µM 
± 16.80 for hFis1 transfected cells). 
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Figure 6 Identification of hFis1 potential interacting partners  
(A) Full length hFis1 interacts with itself but not with Drp1 or Mfn1 in the two-
hybrid system. The PJ694A yeast two-hybrid reporter strain was transformed 
with the indicated bait and fish plasmids and interaction strength was assessed 
on selective media (mild conditions His- ; stringent conditions His-, Ade-). The 
interaction between pGBDUT7-T and pGADT7-p53 is shown as a positive 
control. Removal of the C-terminus abolishes self interaction. (B) List of positive 
clones found in the yeast two-hybrid screen. 
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Figure 7 Expression of hFis1 in yeast results in growth defect 
(A) Overexpression of hFis1 affects growth on glucose, galactose and glycerol 
in solid media. wt BY4741, ΔFis1, and BY4741 transformed with high and low 
expression vectors encoding hFis1 were streaked on agar plates containing the 
indicated carbon source, and left 3 days at 30°C. (B) Overexpression of hFis1 
affects growth in SG liquid media. Growth was assessed in wt PJ694A, wt 
BY4741, ΔFis1, and BY4741 or PJ694A transformed with high or/and low 
expression vectors encoding hFis1 by measuring OD600 at different time 
points. 
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Figure 8 hFis1 and Drp1 oligomers formation.  
CHAPS-solubilized mitochondrial extracts from Hela cells transfected with His-
Fis1 (A) , His-Fis1ΔTM (B), Drp1 (C) or Drp1K38A (D) were loaded on a Superdex 
200 column. Fractions corresponding to the indicated molecular weights were 
collected and analyzed by SDS-PAGE and Western blot with antibodies against 
hFis1 or Drp1. Endogenous (Endog.) and His-Fis1ΔTM are indicated with arrows. 
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Figure 9 hFis1 potential interacting partner  
Affinity Chromatography on Ni-NTA Agarose. Rat mitochondria were isolated as 
described, solubilized in 4% CHAPS and incubated overnight in the presence or 
absence of rHis-Fis1ΔTM. Protein extracts were then applied to a Ni-NTA 
Agarose column and allowed to separated by gravity flow. After washing, bound 
proteins were eluted with 300 mM imidazole. 
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Figure S1 hFis1 does not complement ΔFis1 
Representative images of yeast mitochondria. Yeast of the indicated genotype 
were transformed with mtGFP, grown to mid-log phase and fluorescence was 
visualized in live cells with an epifluorescence microscope. 
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Chapter 3: The mitochondrial fission protein 
hFis1 requires the endoplasmic reticulum 
gateway to induce apoptosis 
 
Abstract 
Mitochondrial fission ensures organelle inheritance during cell division and 
participates in apoptosis. The fission protein hFis1 triggers caspase-dependent 
cell death, by causing the release of cytochrome c from mitochondria. Here we 
show that mitochondrial fission induced by hFis1 is genetically distinct from 
apoptosis. In cells lacking the multidomain proapoptotic Bcl-2 family members 
Bax and Bak (DKO), hFis1 caused mitochondrial fragmentation but not 
organelle dysfunction and apoptosis. Similarly, a mutant in the intermembrane 
region of hFis1 induced fission but not cell death, further dissociating 
mitochondrial fragmentation from apoptosis induction. Selective correction of 
the endoplasmic reticulum (ER) defect of DKO cells restored killing by hFis1, 
indicating that death by hFis1 relies on the ER gateway of apoptosis. 
Consistently, hFis1 did not directly activate BAX and BAK, but induced Ca2+-
dependent mitochondrial dysfunction. Thus, hFis1 is a bifunctional protein that 
independently regulates mitochondrial fragmentation and ER-mediated 
apoptosis. 
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Introduction 
 
The mitochondrial network is highly dynamic 
Mitochondria are crucial organelles in life and death of eukaryotic cells. They 
participate in numerous metabolic reactions, provide most of the energy 
required for endoergonic processes, and play a key role in Ca2+ signaling, 
apoptosis and aging (Rizzuto et al., 2000; Ferri and Kroemer, 2001; Dufour and 
Larsson, 2004). This functional versatility is matched by their structural 
plasticity. Mitochondria are dynamic organelles that continuously undergo 
fusion and fission (Okamoto and Shaw, 2005). Mounting evidence indicates that 
the equilibrium between fusion and fission is crucial for several key cellular 
processes, and that mitochondrial shape is finely regulated in response to 
intracellular needs and extracellular signals (Westermann, 2002; Bossy-Wetzel 
et al., 2003).  
 
Fusion requires Mitofusins and Opa1 
Fusion is required to maintain mtDNA integrity and therefore mitochondrial 
function(Ono et al., 2001). In higher metazoan, mitochondrial fusion is driven by 
two GTPases of the outer membrane, Mitofusin (Mfn) 1 and 2 (Santel and 
Fuller, 2001; Legros et al., 2002; Chen et al., 2003; Santel et al., 2003). Mfns 
appear to play distinct roles in fusion, as suggested by their different rates of 
GTP hydrolysis and substantiated by the different morphology of mitochondria 
in single Mfn knockout fibroblasts (Chen et al., 2003; Ishihara et al., 2004). 
Consistent with this, Opa1, a GTPase of the inner membrane, requires Mfn1 but 
not Mfn2 to promote mitochondrial fusion (Cipolat et al., 2004). Disruption of 
fusion results in cellular dysfunction. Mfn-null and Opa1-RNAi cells display 
reduced respiration, loss of mitochondrial membrane potential and inhibition of 
cell growth (Chen and Chan, 2005). In addition, proteins involved in 
mitochondrial fusion can protect cells from apoptosis, as shown by gain and 
loss of function approaches (Lee et al., 2004; Sugioka et al., 2004). 
 
Fission requires Fis1 and Drp1 
Mitochondrial fission in mammals involves at least two proteins: dynamin 
related protein 1 (Drp1) and Fis1. Drp1 is a cytosolic GTPase, which has been 
proposed to couple GTP hydrolysis to membrane constriction and fission 
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(Smirnova et al., 2001). Fis1 is an outer membrane protein evenly distributed on 
the surface of mitochondria (James et al., 2003). Its N-terminal domain is 
exposed to the cytoplasm and forms a tetratricopeptide (TPR)-like fold(Suzuki 
et al., 2003). The C-terminus of Fis1 harbors a predicted transmembrane 
domain and a short stretch of amino acids facing the intermembrane space 
(IMS). Fis1 is thought to recruit Drp1 to punctuate structures on mitochondria. It 
is therefore considered the limiting factor in the fission reaction (Stojanovski et 
al., 2004).  
 
Apoptosis and mitochondrial morphology: a controversial issue 
Pro- and anti-apoptotic members of the Bcl-2 family regulate the mitochondrial 
participation in the apoptotic cascade (Danial and Korsmeyer, 2004). Activation 
of the mitochondrial pathway results in the release of apoptogenic factors, such 
as cytochrome c, in the cytosol, where they are required to fully activate effector 
caspases. In most cells, this release is accompanied by fragmentation and 
important remodeling of the internal structure of mitochondria (Frank et al., 
2001; Scorrano et al., 2002), and both Drp1 and Fis1 have been implicated in 
these pathways. Their silencing confers resistance to some apoptotic stimuli 
(Lee et al., 2004), while mitochondrial fragmentation induced by Fis1 
overexpression is followed by mitochondrial permeabilization, caspase 
activation and cell death (James et al., 2003). In addition, Drp1 was shown to 
participates in cristae remodeling elicited by the BH3-only proapoptotic Bcl-2 
family member Bik (Germain et al., 2005). However, the relationship between 
apoptosis and mitochondrila morphology is unclear, and whether fission always 
results in increased susceptibility to death remains to be established. For 
example, mitochondrial fragmentation can in some cases prevent apoptosis by 
blocking the Ca2+ waves required for apoptotic signals amplification (Szabadkai 
et al., 2004). In S. cerevisiae the Drp1 orthologue, Dnm1p, also favours 
apoptosis. This pro-death activity is blocked by the antiapoptotic proteins Bcl-2 
and Bcl-xL but also by the yeast Fis1 orthologue, fis1p (Fannjiang et al., 2004). 
Thus, at least in yeast, mitochondrial shaping proteins and Bcl-2 family 
members display some functional redundancy. The participation of 
mitochondrial shaping proteins in apoptosis is further substantiated by the 
observation that mitochondrial scission sites are enriched in Drp1, Mfn2 and the 
proapoptotic protein Bax (Karbowski et al., 2002). Moreover, the 
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overexpression of Mfn2, as well as silencing of hFis1 interferes with 
translocation of Bax to mitochondria (Lee et al., 2004; Neuspiel et al., 2005), 
and the pro-fusion Mfn2 physically interacts with Bcl-XL and the C. elegans 
orthologue CED-9 (Delivani et al., 2006).  
 
Aim of our study 
Several central questions remain open. First, it is unclear whether apoptosis 
and mitochondrial fission are related processes, or whether one can occur 
independently from the other. Second, the role of proapoptotic proteins in 
mitochondrial fission has to be elucidated. Last, it is unknown how promotion of 
fission results in caspase-dependent death. We therefore undertook a genetic 
analysis exploring mitochondrial fission and killing by hFis1 in cells deficient for 
the multidomain proapoptotics BAX and BAK.  
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Material and Methods 
 
Molecular Biology 
Full length hFis1, and Δ1-32 hFis1 were subcloned into the XbaI and EcoRI 
sites of pCI. A Myc-tag sequence was inserted by PCR at the 5’ end of the 
sequence. The K138R mutant of Fis1 was generated by site specific 
mutagenesis. All constructs were confirmed by sequencing. YFP-hFis1 was 
previously described (James et al., 2003).  
 
Reagents, cell culture and transfection  
MEFs were cultured as described before (Scorrano et al., 2003). Transfection 
was performed using Transfectin Lipid Reagent (Biorad) following manufacturer 
instructions. Cyclosporine H was generously provided by P. Bernardi (U. of 
Padova). All chemicals, unless specified, were from Sigma. 
 
Real time imaging of mitochondrial membrane potential 
1x105 MEFs plated on 24 mm round glass coverslips were transfected and after 
24 hrs loaded with 20 nM TMRM dissolved in HBSS supplemented with 1.5 µM 
cyclosporine H (a P-glycoprotein inhibitor) or cyclosporine A for 30 minutes at 
37°C. Cells were then placed on the stage of an Olympus IMT-2 inverted 
microscope equipped with a CellR imaging system. After identification of GFP 
positive cells, sequential images of TMRM fluorescence were acquired every 60 
s using exposure times of 30 ms with a 40X, 1.4 NA Plan Apo objective 
(Olympus). Cells were excited using a 525/20 BP excitation filter and emitted 
light was acquired using a 570/ LP filter. Images were stored and analysis of 
TMRM over mitochondrial regions of interest was performed as described in 
(Scorrano and Korsmeyer, 2003).  
 
Confocal imaging and morphometric analysis 
4x105 MEFs plated on 13 mm diameter glass coverslips (VWR) were 
transfected as indicated in the figure legends and after 24 hrs were incubated in 
Hank’s Balanced Salt Solution (HBSS) supplemented with 10 mM Hepes. For 
confocal images of mitochondrial network, red-channel images were acquired 
using the detector assembly of a Nikon Eclipse E600FN microscope equipped 
with a Biorad Radiance 2100 Confocal Laser Scanning system. Morphometric 
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analysis was performed as described (Cipolat et al., 2004). Cells were scored 
with fragmented or coalesced mitochondria when more than 50% of the objects 
in the image (i.e. mitochondria) displayed aberrant morphology (either 
fragmented or coalesced). For confocal imaging of mitochondrial movement, 
mtRFP fluorescence was imaged using a Nikon Eclipse TE300 inverted 
microscope equipped with a spinning-disk Perkin Elmer Ultraview LCI confocal 
system and a Orca ER 12-bit CCD camera (Hamamatsu). 
 
Immunofluorescence 
6x105 MEFs plated on 13 mm diameter glass coverslips (VWR) were 
transfected as indicated in the figure legends and after 24 hrs 
immunofluorescence was performed as described in (Griffiths et al., 1999). 
Briefly, cells were fixed in 0.25% (w/V) paraformaldehyde, incubated overnight 
with anti Bak (Ab1, Calbiochem), washed and then incubated with TRITC-
conjugated isotype matched antibody. Alternatively, cells were fixed in 4% (w/V) 
paraformaldehyde, incubated overnight with anti-Bax N20 (Santa Cruz) and 
anti-cytochrome c (BD Biosciences) washed and then incubated with TRITC- 
and FITC–conjugated isotype matched antibodies. 
 
Electron Microscopy 
MEFs (5x106 cells) transfected with either bGal or HA-hFis1 were fixed in a 
2.5% (V/V) solution of glutaraldehyde in PBS for 30 min. Conventional electron 
microscopy was then performed as described in (Scorrano et al., 2002).  
 
Analysis of Cell Death 
6x104 MEFs of the indicated genotype grown in 12-well plates were 
cotransfected with pEGFP and the indicated vector and after 48 hrs were 
treated as detailed in the figure legends. Cells were then collected and stained 
with Annexin-V-Alexa568 according to the manufacturer protocol. Apoptosis 
was measured by flow cytometry (FACSCalibur, BD) as the percentage of 
annexin-V positive events in the GFP positive population. 
 
Subcellular Fractionation 
MEFs transfected as indicated were harvested, resuspended in isolation buffer 
(IB, 0.2 M sucrose, 10 mM Tris-MOPS pH 7.4, 0.5 mM EGTA-Tris) and 
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mitochondria were isolated by standard differential centrifugation. Light 
membranes, which included ER and peroxisomes, were obtained by a 
100000g, 30 min centrifugation of the post-mitochondrial supernatant. Protein 
concentration was determined by BCA (Pierce).  
 
Recombinant protein purification 
Full-length human FIS1 was cloned in pET15b (Novagen) and the His-tagged 
hFis1 was expressed in E. coli (BL21DE3). Following induction with IPTG, 
bacteria were lysed, monomeric FIS1 was recovered in the soluble bacterial 
fraction, and purified by chromatography on nickel- nitriloacetic acid–agarose 
followed by Q-Sepharose resin. The protein was stored in 25mM Tris/HCl, 
100mM NaCl, 0.2mM dithiothreitol and 30% (V/V) glycerol, pH 7.5, at -80°C. 
p7/p15 recombinant BID was produced, purified and cleaved with caspase 8 as 
described in (Scorrano et al., 2002). 
 
In vitro assays and crosslinking  
Purified mitochondria (0.5 mg/ml) were incubated at 37°C with p7/p15 BID (3.5 
ng) or with r-HisFIS1 (125 ng) in experimental buffer (EB, 125 mM KCl, 10 mM 
Tris-Mops pH 7.4, 10 µM EGTA-Tris, 1 mM Pi, 5 mM Glutamate 2.5 mM 
Malate) in the presence of cytosolic extract (0.5 mg/ml) . After 30 min, 
mitochondria were centrifuged at 8000g for 5 min. For BAX activation and 
insertion, mitochondria were resuspended in 0.1 M Sodium Carbonate pH 11.5 
and incubated on ice for 30 minutes. After spinning at 100000g for 30 min, 
proteins in the pellet and the supernatant were separated by SDS-PAGE. BAK 
oligomerization was assessed as previously described (Scorrano et al., 2002). 
 
Immunoblotting  
Protein extracts were separated by SDS-PAGE (NuPAGE, Invitrogen), 
transferred onto PVDF membranes (Millipore) and probed using rabbit 
polyclonal anti-BAK antibody (1:1000 Upstate), rabbit polyclonal anti-BAX 
(1:1000 Upstate), rabbit anti-hFis1 antibody, anti-MnSOD (Stressgen 
Biotechnologies), anti LDH (1:1000 Fitzgerald Industries International) anti-
Tom20 (1:1000 Santa Cruz) or anti-actin (1:3000 Chemicon International). 
Horseradish peroxidase conjugated secondary antibodies (Amersham) were 
used followed by detection by chemiluminescence (Amersham). 
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Cell Sorting 
100x106 transfected MEFs were analyzed by light forward and side scatter and 
for YFP fluorescence through a 530 nm band pass filter as they traversed the 
beam of an argon ion laser (488 nm, 100 mW) of a FACSAria (Becton 
Dickinson Biosciences, San Jose CA). Untransfected control MEF cells were 
used to set the background fluorescence. Sorted cells were checked for viability 
by Trypan Blue exclusion.  
 
Respiratory assays 
Intact or digitonin (0.01%, w/v) permeabilized MEFs (5x106 cells) transfected 
with either β-Gal or HA-hFis1 were incubated in 0.5 mL of HBSS or EB (125 
mM KCl, 10 mM Tris-Mops pH 7.4, 10 µM EGTA-Tris, 1 mM Pi, 5 mM 
Glutamate 2.5 mM Malate), respectively. Cellular oxygen consumption was 
measured using a Clarke-type oxygen electrode (Hansatech Instruments).  
 
Calcium Retention Capacity (CRC).  
After sorting, YFP-positive MEFs (5x106 cells) were incubated in 1 mL of EB 
supplemented with digitonin (0.01% w/V) for 5 min. After permeabilization of the 
plasma membrane, 2,5-di-(tert-butyl)-1,4 benzohydroquinone (tBuQH, 100 µM) 
was added before measurement to inhibit SERCA pumps. The CRC of 
mitochondria was assessed using the fluorescent Ca2+ indicator Calcium 
Green-5N (1 µM, Molecular Probes) in a PerkinElmer Life Sciences LS50B 
spectrofluorimeter as described previously (Fontaine et al., 1998).  
 
In gel ATPase activity 
Mitochondria were isolated as described previously and lysed for 10 min in 1 
mM aminocaproic acid, 100 mM Bis-Tris pH 7.0, 2% (w/V) n-dodecylmaltoside 
at 4°C. After centrifuging for 30 min at 20000g, protein concentration of the 
solubilized supernatant was measured by Bradford assay and equal amounts of 
protein were separated by Blue Native Gel Electrophoresis as described in 
(Schagger, 1995). After running the first dimension, ATPase activity was 
assessed directly in the gel by Incubating it for 2 hours in a solution containing 
35 mM Tris, 270 mM glycine, 14 mM MgSO4, 0.2% Pb(NO3)2, 8 mM ATP, pH 
7.8 (Nijtmans et al., 2002).  
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Results 
 
hFis1 independently regulates mitochondrial fission and cell death. 
To determine which domains of hFis1 regulate fission and death, we had 
generated a set of mutants in different regions of the molecule (Figure 1A). We 
deleted the first α helix of the TPR motif (hFis1Δ1-32), removed the TM and IMS 
domains (hFisΔTM), and introduced a point mutation in the short stretch of amino 
acids protruding in the IMS (hFis1K148R). Following transfection of Mouse 
Embryonic Fibroblasts (MEFs), levels of these mutants were comparable, as 
judged by immunoblotting (Figure S1A). As already shown, expression of hFis1 
in MEFs led to fragmented, punctiform organelles, whereas hFis1Δ1-32 promoted 
coalescence of mitochondria in larger, round structures clustering around the 
nucleus (Figure 1, B and quantification in C). Mutation in the IMS stretch and 
removal of the positive charges resulted in mistargeting of the protein to other 
intracellular membranes, including ER ((Stojanovski et al., 2004) and our 
unpublished observation), consistent with what was observed when the C-
terminal of the molecule was tagged (Yoon et al., 2003). However, a 
conservative substitution of Lysine 148 to more positive Arginine did not affect 
mitochondrial localization of hFis1 (Supplementary Figure 1). This mutant 
retained the ability to fragment mitochondria, fission being undistinguishable 
from that induced by wt hFis1 (Figure 1, B and quantification in C). In addition it 
did not interfere with mitochondrial fusion (not shown).  
Removal of the α1 helix, abolished both fission and apoptosis induced by hFis, 
suggesting that excessive mitochondrial fission caused death of mammalian 
cells (Figure 1D)(Yu et al., 2005). Surprisingly, the hFis1K148R mutant also failed 
to induce cell death (Figure 1D), suggesting that the C-terminus of hFis1 not 
only regulates mitochondrial localization, but also impinges on apoptosis 
induction. Moreover, this observation indicates that fission is not sufficient to 
induce cell death, at least in the case of hFis1. 
Expression of hFis1 results in the release of apoptogenic factors from the IMS 
(James et al., 2003), albeit the underlying molecular mechanism is not clear. To 
investigate the role of proapoptotic Bcl-2 family members in this process we 
turned to a genetic model of Bax, Bak-/- (DKO) MEFs. hFis1 promoted 
mitochondrial fission also in the absence of Bax and Bak (Figure 2, A and 
quantification in B), indicating that these proteins do not participate in organelle 
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scission. On the other hand, DKO cells remained viable following hFis1 
expression (Figure 2C), even after 3 days, further dissociating fission and 
apoptosis. We also investigated interdependence between fission and death 
using staurosporine (STS), which activates Drp1-dependent fission early in the 
course of apoptosis (Frank et al., 2001). STS induced mitochondrial 
fragmentation in both wt and DKO MEFs, but as expected, failed to trigger 
death in DKO cells (Figure S2). Silencing of hFis1 interfered only partially with 
STS-induced fission (not shown), suggesting that mechanisms independent 
from hFis1 are recruited by this broad range kinase inhibitor. Taken together, 
these results suggest that two separate pathways operate downstream of 
hFis1: one that controls mitochondrial morphology and requires an intact N-
terminus, and a second that triggers cell death, depends on crucial amino acids 
of the IMS region and requires Bax and Bak.  
 
Bax and Bak are required for mitochondrial dysfunction and death induced by 
hFis1 
We had previously reported that hFis1 induced Δψm heterogeneity and 
mitochondrial dysfunction. To further investigate the relationship between 
mitochondrial dysfunction, apoptosis and fragmentation, we analyzed 
membrane potential (Δψm) by real-time imaging of wt MEFs loaded with the 
potentiometric dye tetramethyl rhodamine methylester (TMRM). As hFis1 
induced reduction in Δψm was only modest, we decided to use Oligomycin to 
enhance it. Oligomycin is a F1F0ATPase inhibitor, which unveils latent 
mitochondrial dysfunction, by inducing depolarization of damaged organelles 
that maintain their membrane potential by reversal of the ATPase (Irwin et al., 
2003). As expected, Δψm remained constant in control transfected wt MEFs 
upon treatment with oligomycin, while mitochondria expressing wt hFis1 but not 
hFisK148R underwent depolarization (Figure 3, A and quantification in B). On the 
other hand, hFis1 did not cause loss of Δψm in response to oligomycin in DKO 
cells (Figure 3, C and quantification in D).  
This difficulty in maintaining Δψm, could indicate that hFis1 affects respiration 
and mitochondria ATP production. We therefore measured oxygen consumption 
in intact and digitonin-permeabilized cells and found that hFis1 did not 
significantly affect basal or uncoupled respiration of intact wt MEFs (Figure 4A). 
These results were confirmed in cells permeabilized with digitonin whose 
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mitochondria were energized using substrates for different respiratory chain 
complexes (Figure 4B). Thus, transient expression of hFis1 does not impair 
mitochondrial respiration, irrespective of the substrate used to feed the 
respiratory chain. We also assessed mitochondrial ATPase function by a 
specific in gel analysis. ATPase activity of cells expressing hFis1 was 
equivalent to that of mock-transfected ones (Figure 4C). Accordingly, cellular 
ATP content following expression of hFis1 remained unchanged for up to 3 
days (3.0±0.5 µM in mock vs.  2.7±0.22 in hFis1-transfected cells at 24 hrs; 
3.7±0.2 vs. 3.9±0.7 at 48 hrs; 2.8± 0.3 vs.  2.9±0.5 at 72 hrs; n=3 ± SE).  Taken 
together, these data indicate: (i) that apoptosis and organelle dysfunction 
induced by hFis1 correlate and require Bax and Bak ; (ii) that mitochondrial 
dysfunction by hFis1 might not be caused by an impairment of mitochondrial 
respiration and ATP synthase activity (iii) that fragmented mitochondria are not 
necessarily dysfunctional; 
 
The Endoplasmic Reticulum Gateway regulates apoptosis induced by hFis1.  
In accordance with previous studies, MEFs expressing hFis1 displayed a 
markedly diffuse cytochrome c immunostaining pattern, a picture similar to that 
observed in cells expressing Bax (Figure 5A). As the presence of Bax and Bak 
seemed required for hFis1 induced death, we tested whether hFis1 triggered 
direct activation of these proapoptotic proteins. We first employed an in vitro 
assay using purified organelles and recombinant proteins. Incubation of isolated 
mitochondria with purified cytosol and recombinant active truncated BID (tBID) 
resulted in the insertion of Bax in the mitochondrial membranes (Figure 5B) and 
in oligomerization of Bak (Figure 5C). Recombinant HisFIS1 was conversely 
unable to induce both Bak oligomerization and Bax insertion (Figure 5, B and 
C). tBID, but not hFis1, alos induced Bax and Bak activation in situ, as shown 
by immunostaining with antibodies that specifically recognize the activated 
forms of these proteins (Figure 5, D and E).  
The lack of direct activation of Bax and/or Bak by hFis1 prompted a more 
detailed evaluation of its killing mechanism. DKO cells are resistant to all kinds 
of intrinsic stimuli tested so far. The ones involving the oligomerisation of Bax 
and/or Bak in the OMM, as well as the ones relying on the ER gateway 
(Scorrano et al., 2003). Indeed this cells display a reduced ER steady state 
Ca2+ concentration ([Ca2+]ER). Selective correction of the ER and mitochondrial 
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defect of DKO cells by expression of sarcoplasmic endoplasmic reticulum Ca2+ 
ATPase (SERCA) or by mitochondrially targeted Bax (mtBax) enabled us to test 
which of these pathways was recruited by hFis1 (Scorrano and Korsmeyer, 
2003). As expected, apoptosis by tBID totally depended on the correction of the 
mitochondrial pathway. On the other hand, hFis1 induced apoptosis only in the 
DKO-SERCA corrected MEFs (Figure 6A). Accordingly, culturing wt MEFs in 
low Ca2+ to deplete intracellular stores, protected them against hFis1 induced 
cell death, whereas this manoeuvre had non effect on tBID induced apoptosis 
(Figure 6B). The mitochondrial dysfunction triggered by hFis1 in DKO cells also 
depended on ER Ca2+ levels, as shown by correction of the ER defect by 
SERCA (Figure 7, A and quantification in B). Taken together, these experiments 
show that the apoptotic program elicited by hFis1 is controlled by the ER death 
gateway and requires adequate [Ca2+]ER.  
 
Killing by hFis1 involves mitochondrial permeability transition and production of 
reactive oxygen species.  
Apoptotic stimuli passing trough the ER gateway can impinge on the 
mitochondrial permeability transition pore (PTP), a Ca2+-dependent inner 
mitochondrial membrane channel. The dysregulated opening of the PTP 
participates in several death pathways (Bernardi et al., 1999). We wished to test 
whether mitochondrial dysfunction induced by hFis1 could be ascribed to a 
dysregulation of PTP opening. To this end, we tested the effect of cyclosporine 
A (CsA), a well characterized inhibitor of the PTP (Bernardi et al., 1999). As 
shown in Figure 7C and D, CsA efficiently prevented depolarization induced by 
oligomycin in MEFs expressing hFis1. We also wondered whether Reactive 
Oxygen Species (ROS), which are positive regulators of PTP opening, played a 
role in hFis1 induced dysfunction. We therefore treated cells with the 
antioxydant N-acetylcysteine (NAC), which is known to block PTP opening 
(Kowaltowski et al., 2001; Reid et al., 2005). NAC blocked both apoptosis 
(Figure 6B) and mitochondrial dysfunction (Figure 7, C and D) induced by 
hFis1, further substantiating a role for PTP.  
To establish whether a link existed between the PTP and the requirement for 
adequate [Ca2+]ER we decided to measure Ca2+ retaining capacity (CRC), an 
indicator of PTP open probability, in mitochondria expressing different levels of 
hFis1. After transfection of wt MEFs with a YFP-tagged version of hFis1 cells 
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were sorted by FACS, and expression was confirmed by specific 
immunoblotting of sorted samples (Figure 7E). Increased hFis1 resulted in 
markedly reduced mitochondrial CRC in these digitonin permeabilized, sorted 
cells (Figure 7, F and quantification in G). Conversely, hFis1K148R, did not 
reduce CRC (Figure 7, F and quantification in D). These results show that hFis1 
regulates PTP and increases its opening probability, independently from its role 
in mitochondrial fission. 
Transient openings of the PTP have been associated with mitochondrial 
remodeling, which ensures complete release of cytochrome c. We therefore 
verified whether mitochondria of cells expressing hFis1 displayed an altered 
ultrastructure. Electron microscopy showed that in approximately 40% of the 
mitochondria the expression of hFis1 resulted in a more positive curvature of 
the cristae and in a widening of the narrow tubular junction (Figure 4).  
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Discussion 
 
Changes in mitochondrial shape have been recently identified as a common 
subroutine of apoptosis. Deletion of molecules governing mitochondrial fusion 
impairs function of the organelle, while excess fission results in cytochrome c 
release and apoptosis. An emerging view predicts a linear relation between 
fragmentation of mitochondria and their permeabilization. Whether and how 
fission necessarily results in permeabilization of mitochondria is however largely 
unknown. A current model implies that components of the mitochondrial fission 
machinery can cross-talk with members of the Bcl-2 family to regulate egress of 
cytochrome c from mitochondria. Multidomain proapoptotic members are likely 
candidates to participate in the release of proapoptotic factors after 
fragmentation of the organelles, but their role in this process remains unclear. 
Here we genetically dissected the mechanism of death by the fission protein 
hFis1 and found that fragmentation of mitochondria and apoptosis can occur 
independently.  
 
hFis1 does not require Bax and Bak to fragment mitochondria. 
Bcl-2 family members play multiple roles in the contribution of ER and 
mitochondrial to apoptotic cascades (Scorrano and Korsmeyer, 2003). Based 
on the ability of Bax to promote mitochondrial shape changes and on its 
colocalization with sites of fission, proapoptotic proteins have been suggested 
to participate in the apoptotic fragmentation of mitochondria (Frank et al., 2001; 
Karbowski et al., 2002). However, the mitochondrial fission protein hFis1, and 
the death stimulus staurosporine, triggered mitochondrial fragmentation 
independently from the presence of Bax and Bak, meaning that Bax and Bak 
might not be necessary for all kinds of fragmentation. Besides, hFis1 and STS 
failed to induce death in the absence of Bax and Bak, suggesting that 
mitochondrial fission and cell death can occur independently. Accordingly, BclXL 
blocks hFis1 induced apoptosis while it does not affect fission (James et al., 
2003).  
DKO cells display a reduction in the steady state ER Ca2+ levels and therefore 
proved informative to address the role of Ca2+ in controlling mitochondrial 
shape. These cells displayed slightly shorter mitochondria and underwent 
equivalent fission when hFis1 was expressed. This implies that adequate 
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[Ca2+]ER, crucial for several mitochondrial functions, is not required to control 
fission of the organelle. However, it could be important for fusion, as Ca2+ is 
known to regulates several membrane fusion proteins and to participates in 
both exocytic vesicles and ER membrane fusion events (Jackson and 
Chapman, 2006; Vedrenne and Hauri, 2006). In addition, dynamic changes in 
cytosolic and/or mitochondrial Ca2+ were shown to modulate mitochondrial 
shape (Yi et al., 2004). It would be interesting to determine whether 
mitochondria from DKO cells fuse as efficiently as normal mitochondria, and 
whether reduced [Ca2+]ER could explain the presence of shorter mitochondria. 
 
The ER gateway controls apoptosis by hFis1 
The resistance of DKO cells to death induced by hFis1 suggested that hFis1 
would directly or indirectly activate Bax and Bak to provide an efflux pathway for 
cytochrome c. A set of in vitro experiments using purified organelles and 
recombinant proteins excluded a direct effect of hFis1 on Bax and Bak 
activation, as well as on cytochrome c release (JC Martinou, unpublished 
results). This did not depend on additional factors missing in this reconstituted 
assay, since activation of multidomain proapoptotics was also excluded in situ. 
These surprising results suggest that in the case of hFis1 induced fission, 
insertion and oligomerization of Bax at sites of fragmentation does not occur 
like in other paradigms of apoptosis (Frank et al., 2001).  
Selective correction of ER vs. mitochondrial defect of DKO cells has been 
successfully used to define the gateway through which a given apoptotic 
stimulus passes (Scorrano and Korsmeyer, 2003). hFis1 induced death in 
SERCA-, but not in mtBAX-corrected DKO MEFs. Further evidences showed 
that hFis1 required adequate ER Ca2+ to kill, placing it genetically downstream 
of the ER gateway of apoptosis. Our results provide a molecular explanation for 
the previous finding that death by hFis1 is blocked by Bcl-XL (James et al., 
2003), which also regulates release of Ca2+ from the ER (Li et al., 2002). High 
increases in cytosolic Ca2+ directly impact on mitochondria, and can cause their 
permeabilization. Therefore, the reduction in capacitative Ca2+ entry (CCE) 
promoted by hFis1 (Frieden et al., 2004) as well as the reduced rate and extent 
of ER refilling can be viewed as compensatory mechanisms to protect cells from 
cytosolic Ca2+ rises.  
 
 88 
Latent mitochondrial dysfunction precedes death by hFis1.  
Mitochondria lacking essential components of mitochondrial fusion display 
multiple functional defects, including greatly reduced respiratory rates (Chen et 
al., 2005). This holds true also in yeast, where most deletion mutants of genes 
involved in mitochondrial fusion are petite, as a consequence of their respiratory 
incompetence. Moreover, the importance of pro-fusion proteins for cellular 
physiology is confirmed by their ablation in the mouse, which results in early 
embryonic lethality (Chen et al., 2003). We therefore reasoned that increasing 
mitochondrial fission by expressing hFis1 could have similar results.  
A detailed analysis of mitochondrial membrane potential in situ in cells 
expressing hFis1 showed conversely a latent organelle dysfunction, unveiled 
only following treatment with oligomycin. This drug is expected to induce slight 
hyperpolarization, as the inhibition of the F1F0 ATPase blocks diffusion of 
protons back into the matrix of phosphorylating mitochondria. On the other 
hand, oligomycin induced depolarization of wt mitochondria expressing hFis1, 
which most probably maintain their membrane potential by reversal of the 
ATPase. Such a depolarization was not observed in hFis1 transfected DKO 
cells and was restored by genetic correction of DKO with SERCA. It should be 
noted that similar experiments have been performed in HeLa cells, where 
oligomycin had apparently no effect (Frieden et al., 2005). One explanation can 
be found in the short experimental window used by Demaurex and colleagues, 
that precluded to highlight the slow depolarization induced by oligomycin 
(Gugliucci et al., 2002; Irwin et al., 2003). Oxygen consumption measurements 
of intact and digitonin-permeabilized cells ruled out gross impairment of the 
respiratory chain. Moreover, assembly of the ATPase and total cellular ATP 
content were not affected by high levels of hFis1. When hFis1 is 
overexpressed, basic bioenergetics appears therefore to be conserved. It is 
however possible that we missed a bioenergetic defect in our experimental 
conditions. To really assess the effect of hFis1 on mitochondrial function, the 
same experiments should be performed on stable cell lines. Despite several 
attempts, we were not able to establish any stable cell lines, as the 
overexpression of hFis1 seems to stop cell division (not shown).  
Nevertheless, we observed that hFis1 reduces the mitochondrial threshold to 
stresses, as highlighted by the oligomycin-induced depolarization and by the 
decreased CRC. Latent mitochondrial dysfunction unveiled by oligomycin 
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characterizes cells from mouse models of collagen VI deficiency (Irwin et al., 
2003), as well as prostate cancer cells where accumulation of arachidonic acid 
was induced by pharmacological inhibition of its metabolism (Gugliucci et al., 
2002). In both these models, dysfunction was prevented by the PTP inhibitor 
CsA, suggesting a role for this inner mitochondrial membrane channel. 
 
An IMS mutant of hFis1 dissociates fission from PTP opening.  
Known inhibitors of Ca2+-induced PTP opening, CsA and N-acetyl cysteine, 
blocked depolarization induced by oligomycin in mitochondria expressing hFis1. 
Furthermore, CRC of mitochondria expressing high levels of hFis1 was reduced 
by ~50% compared to control organelles, indicating that hFis1 impinges on 
mitochondrial Ca2+ mediated permeability transition. The mechanism by which 
hFis1 reduces the threshold for PTP opening remains to be investigated. 
Recently, it has been suggested that mitochondrial fission is required for the 
generation of ROS in a model of hyperglycemia (Yu et al., 2006), suggesting a 
cross talk between the fission machinery and the mechanisms involved in 
production of ROS. It is tempting to speculate that high levels of hFis1 can 
trigger production, or favour accumulation of ROS that in turn lower the Ca2+ 
threshold of the PTP (Chernyak and Bernardi, 1996).  
Mitochondrial dysfunction and death induced by hFis1 was genetically distinct 
from mitochondrial fission. A conservative single amino acid mutant in the short 
IMS stretch of hFis1 completely abolished mitochondrial dysfunction in situ and 
restored CRC to levels found in control mitochondria. These results have 
important implications. First, they point to a crucial role for a previously 
overlooked domain of the molecule. Second, they show that mitochondrial 
dysfunction is not caused solely by fission, since this K148R mutant causes 
efficient fragmentation. Finally, they imply that the hFis1 mutant lacking the first 
α-helix induces PTP-dependent mitochondrial dysfunction and death via its 
intact IMS stretch (Yu et al., 2005). In this view, the IMS stretch could somehow 
communicate with the inner mitochondrial membrane to elicit opening of the 
PTP and perhaps remodelling of the cristae, a process accompanied by 
transient opening of the this channel (Scorrano et al., 2002; Germain et al., 
2005). On this line, we found that approximately 40% of mitochondria 
overexpressing hFis1 displayed a morphology reminiscent of cristae 
remodelling. In conclusion, our genetic dissection illustrates that hFis1 kills via 
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the ER gateway, impinging on Ca2+-dependent, PTP-mediated mitochondrial 
dysfunction.  
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Figures 
Figure 1 Mutational analysis of hFis1 domains required for mitochondrial 
fission and apoptosis.  
(A) Cartoon of constructs used in this study. (B) The N-terminus of hFis1 
controls mitochondrial morphology. Representative images of mitochondrial 
morphology in wt MEFs cotransfected with the indicated plasmid and mtRFP. 
Bar 15 µm.  (C) Morphometric analysis of mitochondrial shape. Cells were 
transfected as in (B) and elongated, fragmented and coalesced mitochondria 
were scored. Data represent mean ± SE of 5 different experiments. (D) Deletion 
of the first α-helix and K148R point mutation abolish hFis1 induced apoptosis. 
WT MEFs were cotransfected with GFP and the indicated plasmids and after 48 
hrs apoptosis was determined as the percentage of GFP positive, Annexin-V 
positive cells by flow cytometry. Data represent mean ± SE of 6 independent 
experiments. 
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Figure 2 hFis1 triggers mitochondrial fission but not apoptosis in Bax-/- 
Bak-/- DKO MEFs  
(A) hFis1 induces fission in the absence of Bax and Bak. Representative 
images of mitochondrial morphology in wt and DKO cells cotransfected with a 
control (β-Gal) or Myc-Fis1 and mtRFP. (B) Morphometric analysis of 
mitochondrial shape was carried out exactly as in Figure 1C. Data represent 
mean ± SE of 5 different experiments.  (C) hFis1 does not trigger cell death in 
DKO  cells. MEFs of the indicated genotype were cotransfected with GFP the 
indicated plasmids. Apoptosis was determined as the percentage of GFP 
positive, Annexin-V positive cells by flow cytometry. Data represent mean±SE 
of 6 different experiments. 
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Figure 3 DKO cells are resistant to hFis1 induced mitochondrial 
dysfunction  
(A, C) Pseudocolor-coded, representative images of TMRM fluorescence 
intensity in wt (A) and DKO (C) cells at 5 (5') and 40 min (40’) of the acquisition 
sequence. MEFs cotransfected with GFP and the indicated plasmids (asterisks) 
after 24 hrs were loaded with TMRM and imaged as described. Oligomycin (2.5 
µg/ml) was added at min 3 of the sequence.  (B, D) Quantification of the 
TMRM fluorescence changes over mitochondrial regions in wt (B) and DKO (D) 
MEFs. Experiments were carried out as (A) and C, respectively. Where 
indicated (arrows), oligomycin (2.5 µg/ml) and FCCP (4 µM) were added. 
Quantification procedure is described in the Experimental Procedure section.  
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 Figure 4 Mitochondrial respiration, ATPase activity and 
intramitochondrial morphology of cells expressing hFis1.  
(A) Oxygen consumption in control and hFis1-expressing intact WT MEFs. 48 
hours after transfection, cells were harvested and 108 cells were incubated in 
HBSS into an oxygen electrode chamber. Where indicated (arrows), the 
uncoupler FCCP (2 µM) and the complex IV inhibitor NaN3 (10 mM) were 
added. (B) Oxygen consumption in control and hFis1-expressing permeabilized 
MEFs. Experiments were as in (A), except that the cells (108) were incubated in 
0.5 mL EB containing 0.01% (w/V) digitonin. Where indicated (arrows), 
glutamate plus malate (G/M, 5/2.5 mM) or succinate (S/Rot 5 mM in the 
presence of 2 µM Rotenone, an inhibitor of complex I), ADP (100 µM), 
oligomycin (2.5 µg/ml), FCCP (60 nM) and NaN3 (1 mM) were added. (C) In-gel 
activity assay of F1-ATPase. Mitochondria from hFis1 transfected and 
untransfected cells were isolated and solubilized in n-dodecylmaltoside. 
Solubilized samples were then separated by BN-PAGE as described in 
experimental procedures. The Blue Native gel was then histochemically stained 
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for ATP hydrolysis activity. Mitochondria isolated from human heart samples 
were loaded as a control. (D) Representative ultrastructure of mitochondria in 
hFis1 expressing cells. Cells transfected with hFis1 were fixed and standard 
electron microsopy images were acquired as described. Bar, 100 nm.   
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Figure 5 hFis1 does not activate BAX and BAK  
(A) hFis1 induces release of cytochrome c. wt MEFs were cotransfected with 
mtRFP and the indicated plasmid. After 24 hrs, cells were fixed, immunostained 
for cytochrome c and confocal images of mtRFP and cytochrome c were 
acquired. Bar, 15 µm. (B) hFis1 does not trigger BAX insertion into 
mitochondrial membranes. Purified mitochondria (50 µg) were incubated with 
p7/p15 BID or with r-HisFis1. Mitochondria were then treated with 0.1 M 
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Na2CO3 and alkali resistant (pellet) and sensitive fractions (supernatant) were 
separated by centrifugation. Proteins were separated by SDS-PAGE and 
immunoblotted using the indicated antibodies.  (C) hFis1 does not induce BAK 
oligomerization. Purified mitochondria (50 µg) were incubated as in (A) and 
proteins were crosslinked where indicated by incubating with 
bismaleimidohexane (BMH, 10 mM) for 15 min. Samples were separated by 
SDS-PAGE and immunoblotted with an anti-BAK antibody. Asterisk, BAK 
multimers. Arrow, BAK monomer. (D) hFis1 does not trigger BAX activation in 
vivo. MEFs were transfected with indicated plasmids and 48 hrs after 
transfection cells were stained for Tom20 and for activated BAX using a BAX-
NT antibody and counterstained with FITC- and TRITC-conjugated isotype 
matched secondary antibodies.  (E) hFis1 does not trigger BAK activation in 
vivo. wt MEFs were cotransfected with the indicated plasmid and mtYFP. After 
48 hrs cells were fixed and immunostained with a monoclonal anti BAK 
antibody and counterstained with a TRITC-conjugated secondary antibody. Bar, 
15 µM. 
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Figure 6 The BAX, BAK ER gateway controls death by hFis1 
(A) hFis1 induced apoptosis is restored in DKO-SERCA but not in DKO-mtBAX 
MEFs. MEFs of the indicated genotype were cotransfected with GFP and the 
indicated plasmids. Apoptosis was determined as the percentage of GFP 
positive, Annexin-V positive cells by flow cytometry. Data represent mean±SE 
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of 6 different experiments. (B) hFis1 induced cell death is inhibited by low 
extracellular [Ca2+] and by NAC. Wt MEFs were transfected as in (A) and after 4 
hours NAC (2.5mM) was added to the media. Apoptosis was monitored 48 hrs 
after transfection. Where indicated (0.1mM Ca2+), wt MEFs were incubated in 
KRB supplemented with EGTA for 3 hours and then maintained in complete 
DMEM containing 0.1mM Ca2 prior to transfection. 
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Figure 7 Mitochondrial dysfunction by hFis1 is mediated by permeability 
transition. 
(A-B) hFis1 induces mitochondrial dysfunction in DKO-SERCA MEFs. DKO-
SERCA MEFs cotransfected with GFP and the indicated plasmid (asterisk) 
were loaded with TMRM and fluorescence was imaged, stored and analyzed as 
described previously. Data represent mean ± SE of 3 independent experiments. 
(C-D) Mitochondrial dysfunction induced by hFis1 is inhibited by CsA and NAC. 
wt MEFs cotransfected with GFP and Myc-hFis1 (asterisk) were loaded with 
TMRM in the presence of 2.5 mM NAC or 1.5 µM CsA when indicated. TMRM 
fluorescence over mitochondrial regions was imaged, stored and analyzed as 
described previously. Where indicated (arrows), oligomycin (2,5 µg/ml) and 
FCCP (4 µM) were added. Data represent mean±SE of 5 different experiments. 
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(E) Cell sorting of YFP-expressing wt MEF. Twenty-four hrs after transfection 
with YFP-hFis1 (YFPFis), mtYFP or mtYFP plus hFis1K148R (FisK148R), wt MEFs 
(108) were washed, harvested and sorted as described in the Experimental 
Procedure section. Dot plot histograms of YFP fluorescence in control (upper 
panel) and transfected (lower panel) cells are shown. R2 indicates sorted 
population. Sorted cells were lysed in RIPA buffer and equal amounts of protein 
(40 µg) were separated by SDS-PAGE and immunoblotted with the indicated 
antibodies. (F) Representative traces of mitochondrial Calcium Retention 
Capacity (CRC). Sorted (5x106) cells were permeabilized with digitonin (0.001% 
w/V) in experimental buffer and Ca2+ uptake was measured following the 
fluorescence changes of the Ca2+ indicator Ca-Green. Where indicated, 
(arrows) 5 µM Ca2+ were added. Final volume 1 mL, pH 7.4, 37°C. (G) 
Quantitative analysis of CRC of mitochondria from digitonin permeabilized cells. 
CRC of mitochondria of sorted wt MEFs transfected with the indicated plasmids 
was measured exactly as in (F). Data represent mean ± SE of 5 different 
experiments 
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Figure S1 Expression and localisation of hFis1 mutants  
(A) Expression levels of Myc-Fis1, Myc-Fis1K148R, Myc-Fis Δ1-32,  Myc-Fis Δ1-48. 
48 hours after transfection, cells were lysed and proteins were extracted and 
analysed by SDS-PAGE. 
 (B) Subcellular fractionation of cells transfected with Myc-Fis1, Myc-Fis Δ1-32or or 
Myc-Fis1K148R. 24 hours after transfection mitochondrial, cytosol and light 
membranes (LM) fractions were purified as described in experimental 
procedures. Equal amounts (40 µg) of protein were separated by SDS-PAGE 
and immunoblotted using the indicated antibodies. 
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Figure S2 Staurosporine induces mitochondrial fragmentation but not 
apoptosis in DKO MEFs 
(A) Apoptosis was determined by flow cytometry as the percentage of 
Annexin-V, PI positive cells. Data represent mean ± SE of 5 independent 
experiments. Where indicated, STS (1 µM) was added 10 hrs before assay. 
(B) Representative images of mitochondrial morphology in wt and DKO MEFs 
transfected with mtRFP. 24 hrs after transfection STS (1µM) was added 
where indicated and fluorescence of mtRFP was visualized by confocal 
microscopy 8 hours later. Bar, 15 µm 
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Figure S3 Mitochondrial movement is not enhanced by hFis1.   
MEFs were co-transfected with mtRFP and β-gal or hFis1 and after 24 hours 
mtRFP was imaged by confocal microscopy. Individual frames were acquired 
every 5 s over a 2 min time-frame. In representative images acquired at the 
indicated times single moving mitochondria were pseudocolored in green for the 
sake of clarity. Red bars show point of origin of moving mitochondria. Bar, 1 
µm. 
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Chapter 4: General Discussion and Perspectives 
 
The field of mitochondrial dynamics has virtually exploded in the past 4 years, 
and scientists from very different areas, ranging from ubiquitin/proteasome and 
protein import pathways, to neuronal development and aging, became 
interested in the involvement of mitochondrial morphology in these processes. 
Despite this growing awareness, only few mammalian fission and fusion 
proteins have been identified so far. Much of what we know comes from the 
yeast work, however, there is no guarantee that these mechanisms are 
conserved. Not only many yeast proteins are missing in higher eukaryotes, but 
growing evidence also suggests that significant functional divergence has 
occurred during evolution. In order to get more insight into mammalian 
mitochondrial fission, we analysed the function of hFis1 in mammalian cells, 
and found that this small OMM protein impinges on mitochondria in several 
ways. 
 
Fis1 in Mitochondrial Morphology 
In yeast Fis1 is considered as the receptor for the assembly of the fission 
machinery and recruits Dnm1p, Mdv1p and Caf4p. Based on the effect of its 
overexpression on mitochondrial morphology, Fis1 is thought to have the same 
role in mammals (James et al., 2003; Stojanovski et al., 2004). However 
mitochondrial fission seems to occur even in the absence of Fis1. Although 
knocking down of Fis1 with RNAi leads to a slight elongation of mitochondrial 
tubules, this effect is minor compared to the knock down of Drp1 or the 
expression of the dominant negative form Drp1K38A. In addition, in C.elegans, 
Drp1 is required and sufficient for mitochondrial fission, as the knock down of 
the two orthologues of Fis1 has no impact on mitochondrial morphology 
((Jagasia et al., 2005) and A. Van Der Bliek personal communication). 
Moreover, mammalian Drp1 can be recruited to mitochondria in the absence of 
Fis1 (Lee et al., 2004), suggesting that alternative routes to mitochondrial 
fission exist. As shown in Figure 1, Drp1 could use other receptors to mediate 
mitochondrial division, and fission could also take place in a Drp1-independent 
way. 
On the other hand, several observations suggest that Fis1 could be involved in 
more than one aspect of mitochondrial morphology. In fungi, besides fission 
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and fusion, the tubulation pathway also governs mitochondrial dynamics. The 
tubulation pathway includes Mdm10p, Mmm1p and Mdm12p, mutations or 
deletions of either of these factors converting the mitochondrial network into 
large swollen spheres (Burgess et al., 1994; Sogo and Yaffe, 1994; Berger et 
al., 1997; Hobbs et al., 2001). The tubulation pathway mediates at least three 
processes: actin-mitochondria attachment, formation of tubular mitochondria, 
and anchoring of mtDNA nucleoids (Okamoto and Shaw, 2005).  
None of the proteins involved in tubulation being conserved in higher 
eukaryotes, it is likely that a related process also exists in mammals. No direct 
evidence suggests that Fis1 could impinge on mitochondrial tubulation, 
however, we made several intriguing observations. First the overexpression of 
Fis1 not only fragments mitochondria but also alters their cellular distribution. 
Second, mitochondria move faster and cover longer distances in Fis1 
transfected cells. Third, Fis1 induces the formation of very small, dot-like 
organelles, which differs from the mitochondrial morphology induced by fusion 
inhibition. Finally, the morphology triggered by the Myc-Fis1Δ1-32 mutant is 
reminiscent of the one observed upon disruption of mitochondrial transport 
(Fransson et al., 2003; Varadi et al., 2004; Fransson et al., 2006), and could 
thus result from an impairment of mitochondrial interaction with the 
cytoskeleton. These observations could also be indirect consequences of Fis1 
involvement in mitochondrial fission. However, together with the fact that fission 
does not require Fis1p to occur, they indicate that Fis1 may participate in other, 
yet unknown, pathways to influence mitochondrial morphology. 
 
Fis1 in Mitochondrial Energy Production 
Consistently, EM analysis of Fis1 expressing cells reveals that the internal 
structure of mitochondria is perturbed. Although Fis1 does not seem to be 
required for IMM division (Jakobs et al., 2003), these cells display disorganized 
cristae. It is tempting to speculate that this remodelling of the internal 
compartment correlates with mitochondrial dysfunction. Indeed, cristae 
remodelling is associated with modulation of ATP synthase oligomeric state 
(Frey and Mannella, 2000; Paumard et al., 2002), and Bornhövd and co-
workers recently showed that mutants which destabilize F1F0-ATP synthase 
oligomer formation, have reduced growth rate (Bornhovd et al., 2006). 
Interestingly, these mutants have decreased Δψm, but retain normal ATP 
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Synthase activity, and show no defect in respiration and coupling capacity. The 
authors propose that impairing F1F0-ATP synthase supracomplexes formation 
increases fluidity of the IMM and disrupts “respirosomes” microdomains, 
affecting optimal bioenergetic competence of mitochondria. Whether F1F0-ATP 
synthase oligomerisation is affected in Fis1 overexpressing cells still has to be 
established. However, in the presence of Fis1, we observe the disappearance 
of a high molecular weight band in the BN-Page pattern of mitochondrial 
proteins. It would be interesting to identify these proteins. 
 
Fis1 in Autophagy 
Fis1 has also been reported to play a role in peroxisomes dynamics (Schrader, 
2006). Peroxisomes are single membrane-bound organelles that are important 
for several metabolic pathways such as peroxide metabolism, catabolism of 
purines and polyamines, metabolism of amino acids and lipid metabolism fatty 
acid α- and β-oxidation (Mannaerts and Van Veldhoven, 1993). In addition, 
recent studies have highlighted a role for peroxisomes in the metabolism of 
oxygen free radicals and nitric oxide (Moldovan and Moldovan, 2004; Schrader 
and Fahimi, 2004). Peroxisomes can appear as spherical organelles, but are 
also observed as elongated, tubular structures and small, tubulo-reticular 
networks, which are frequently associated with lipid droplets (Schrader, 2001). 
Consistent with a role in the tubulation of membranes, the knock down of Fis 
has also been reported to induce the tubulation of peroxisomes (Koch et al., 
2005). Interestingly, redundant, damaged or non functional peroxisomes are 
removed by autophagy-related processes (Kiel et al., 2003). It is therefore 
possible that Fis1 induced autophagy is caused by abnormal peroxisomes 
dynamics, and further investigations are required to clarify whether 
micropexophagy or macroautophagy takes place in Fis1 overexpressing cells.  
 
Fis1 in Cell death 
Several cellular processes are associated with changes in mitochondrial 
morphology, and events such as cytoskeleton disruption or inhibition of kinase 
activity could trigger mitochondrial fission. The impressive fragmentation that 
occurs during cell death may have nothing to do with the well regulated process 
of mitochondrial fission, and, although Drp1K38A and Drp1 knock down protect 
from death, mitochondrial shaping proteins may not be involved in the same 
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manner in apoptotic and physiological fission. Accordingly, mounting evidence 
suggests that fusion inhibition, rather than fission enhancement, is likely to be 
involved in the apoptotic fragmentation (Karbowski et al., 2002; Delivani et al., 
2006).  
The behaviour of the K148R mutant as well as our analysis of Fis1 in the Bax-/- 
Bak-/- DKO clearly dissociate the two functions of Fis1. Its killing effect is distinct 
from its role in mitochondrial fission. Accordingly, when co-expressed with Fis1, 
Drp1K38A prevents fission but fails to block death whereas BclXL prevents 
apoptosis without affecting fission. Our study indicates that Fis1 sensitizes 
mitochondria, and increases their susceptibility towards permeabilization by 
Ca2+ signals. A possible explanation would be that it does so by triggering 
cristae remodelling, which is known to favour the release of cytochrome c 
during apoptosis (Scorrano et al., 2002; Germain et al., 2005). The mechanism 
by which Fis1 would affect the mitochondrial internal structure could involve the 
IMS stretch, as mutations within this portion of the molecule abolish death 
induction. Although the Lysine to Arginine mutation is rather conservative, as 
these residues share common biochemical properties, K to R mutations have 
been reported to disrupt several proteins interactions (Haimeur et al., 2004; 
Praefcke et al., 2004; Imoto et al., 2005; Wang et al., 2005). It is difficult to 
imagine that the short C-terminal stretch of Fis1 mediates an interaction with a 
protein of the IMS, however, it could somehow disrupt Fis1 associations with 
other OMM proteins. In this regard, it would be interesting to test whether 
dimerisation of Fis1 is abolished by the K148R mutation. 
 
In conclusion, even though our work did not allow the identification of new 
mitochondrial shaping proteins, it unveiled that hFis1 probably has pleiotropic 
functions, and that mitochondrial dynamics are inextricably linked to various 
cellular processes. The relationship between form and function is an important 
concern in Biology, and Jean-Baptiste de Lamarck was probably not completely 
wrong when he predicted that function dictates organs shape. Future 
characterisation of hFis1 multiple functions will therefore necessarily give more 
insight in the processes governing organelle shape.  
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